Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Evolv Technologies Holdings, Inc.EVLV · Entity 5017 | 10% owner | July 16, 2021 | July 26, 2021 |
| General Catalyst Global Resilience Merger Corp.GCGR · Entity 5448 | Director | April 29, 2026 | April 30, 2026 |
| Health Assurance Acquisition Corp.HAAC · Entity 122106 | Director · Chief Executive Officer | November 12, 2020 | November 13, 2020 |
| Oscar Health, Inc.OSCR · Entity 3582 | 10% owner | March 03, 2021 | March 04, 2021 |
| Revolution Healthcare Acquisition Corp.REVH · Entity 135631 | Director | March 17, 2021 | March 17, 2021 |
| Samsara Inc.IOT · Entity 3218 | Director | March 22, 2024 | March 26, 2024 |
| Teladoc Health, Inc.TDOC · Entity 1547 | Director | April 19, 2021 | April 22, 2021 |
| Wag! Group Co.PET · Entity 77424 | 10% owner | August 09, 2022 | August 09, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Evolv Technologies Holdings, Inc.
Report date July 16, 2021 · Filed July 26, 2021
Jointly reported with General Catalyst GP V, LLC, General Catalyst Group V LP, GC Entrepreneurs Fund V, LP, General Catalyst Group V Supplemental LP, GC Partners Holdings, LP, GCGM Investment Holdings, LP, Fialkow David P, Cutler Joel E
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | IndirectBy General Catalyst Group V, L.P. | 12,774,845 |
Reported balance
Holding disclosure · report date 2021-07-16 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 12,774,845 F1: The Reporting Person acquired a portion of these securities on July 16, 2021 as consideration and in exchange for the Reporting Person's holdings in Evolv Technologies, Inc. ("Old Evolv") pursuant to an Agreement and Plan of Merger dated March 5, 2021, by and among Old Evolv, NewHold Investments Corp. (the predecessor to Issuer) and NHIC Sub Inc., as amended by that certain First Amendment to Agreement and Plan of Merger dated June 5, 2021 (as so amended, the "Merger Agreement") and the other portion of these securities on July 16, 2021, pursuant to that certain Noteholders' Consent dated June 21, 2021, by and among the noteholders identified therein, NewHold Investments Corp. and Old Evolv, entered into in connection with the Merger Agreement. F2: The reported securities are held directly by General Catalyst Group V, L.P. General Catalyst GP V, LLC is the general partner of General Catalyst Partners V, L.P., which is the general partner of General Catalyst Group V, L.P. and GC Entrepreneurs Fund V, L.P. Lawrence Bohn, a member of Issuer's board of directors, Joel Cutler, and David Fialkow are managing directors of General Catalyst GP V, LLC, and, as a result, may be deemed to have voting and dispositive power over the shares held by General Catalyst Group V, L.P. and GC Entrepreneurs Fund V, L.P. Each of the reporting persons and entities disclaims beneficial ownership of the reported securities except to the extent of such person's or entity's pecuniary interest in such securities. |
| Class A Common StockSEC Table I · non-derivative | IndirectBy GC Entrepreneurs Fund V, L.P. | 271,865 |
Reported balance
Holding disclosure · report date 2021-07-16 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 271,865 F1: The Reporting Person acquired a portion of these securities on July 16, 2021 as consideration and in exchange for the Reporting Person's holdings in Evolv Technologies, Inc. ("Old Evolv") pursuant to an Agreement and Plan of Merger dated March 5, 2021, by and among Old Evolv, NewHold Investments Corp. (the predecessor to Issuer) and NHIC Sub Inc., as amended by that certain First Amendment to Agreement and Plan of Merger dated June 5, 2021 (as so amended, the "Merger Agreement") and the other portion of these securities on July 16, 2021, pursuant to that certain Noteholders' Consent dated June 21, 2021, by and among the noteholders identified therein, NewHold Investments Corp. and Old Evolv, entered into in connection with the Merger Agreement. F3: The reported securities are held directly by GC Entrepreneurs Fund V, L.P. General Catalyst GP V, LLC is the general partner of General Catalyst Partners V, L.P., which is the general partner of General Catalyst Group V, L.P. and GC Entrepreneurs Fund V, L.P. Lawrence Bohn, a member of Issuer's board of directors, Joel Cutler, and David Fialkow are managing directors of General Catalyst GP V, LLC, and, as a result, may be deemed to have voting and dispositive power over the shares held by General Catalyst Group V, L.P. and GC Entrepreneurs Fund V, L.P. Each of the reporting persons and entities disclaims beneficial ownership of the reported securities except to the extent of such person's or entity's pecuniary interest in such securities. |
| Class A Common StockSEC Table I · non-derivative | IndirectBy General Catalyst Group V, Supplemental, L.P. | 279,438 |
Reported balance
Holding disclosure · report date 2021-07-16 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 279,438 F1: The Reporting Person acquired a portion of these securities on July 16, 2021 as consideration and in exchange for the Reporting Person's holdings in Evolv Technologies, Inc. ("Old Evolv") pursuant to an Agreement and Plan of Merger dated March 5, 2021, by and among Old Evolv, NewHold Investments Corp. (the predecessor to Issuer) and NHIC Sub Inc., as amended by that certain First Amendment to Agreement and Plan of Merger dated June 5, 2021 (as so amended, the "Merger Agreement") and the other portion of these securities on July 16, 2021, pursuant to that certain Noteholders' Consent dated June 21, 2021, by and among the noteholders identified therein, NewHold Investments Corp. and Old Evolv, entered into in connection with the Merger Agreement. F4: The reported securities are held directly by General Catalyst Group V Supplemental, L.P. General Catalyst GP V, LLC is the general partner of General Catalyst Partners V, L.P., which is the general partner of General Catalyst Group V, L.P., GC Entrepreneurs Fund V, L.P. and General Catalyst Group V Supplemental, L.P. Lawrence Bohn, a member of Issuer's board of directors, Joel Cutler, and David Fialkow are managing directors of General Catalyst GP V, LLC, and, as a result, may be deemed to have voting and dispositive power over the shares held by General Catalyst Group V, L.P., GC Entrepreneurs Fund V, L.P., and General Catalyst Group V Supplemental, L.P. GCGM Investment Holdings, L.P. is a limited partner of General Catalyst Partners V, L.P. with a pecuniary interest in the reported securities. F5: (Continued from Footnote 5) GC Partners Holdings, L.P. is a limited partner of GCGM Investment Holdings, L.P. with a pecuniary interest in the reported securities. Each of the reporting persons and entities disclaims beneficial ownership of the reported securities except to the extent of such person's or entity's pecuniary interest in such securities |
| Performance RightsSEC Table II · derivative / convertible security | IndirectBy General Catalyst Group V, L.P. | Not disclosed |
Reported balance
Holding disclosure · report date 2021-07-16 · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · Balance Not disclosed F6: Each performance right represents a contingent right to receive one share of the Issuer's Class A common stock. Pursuant to an "Earn Out" provision in the Merger Agreement, the performance rights vest upon the Issuer's Class A Common stock achieving a specified price per share as follows: (i) 1/3 of the shares shall be issued if the closing sale price of Class A common stock equals or exceeds $12.50 per share for any period of 20 trading days out of 30 consecutive trading days prior to March 5, 2026; (ii) 1/3 of the shares shall be issued if the closing sale price of Class A common stock equals or exceeds $15.00 per share for any period of 20 trading days out of 30 consecutive trading days prior to March 5, 2026; and (iii) 1/3 of the shares shall be issued if the closing sale price of Class A common stock equals or exceeds $17.50 per share for any period of 20 trading days out of 30 consecutive trading days prior to March 5, 2026. F2: The reported securities are held directly by General Catalyst Group V, L.P. General Catalyst GP V, LLC is the general partner of General Catalyst Partners V, L.P., which is the general partner of General Catalyst Group V, L.P. and GC Entrepreneurs Fund V, L.P. Lawrence Bohn, a member of Issuer's board of directors, Joel Cutler, and David Fialkow are managing directors of General Catalyst GP V, LLC, and, as a result, may be deemed to have voting and dispositive power over the shares held by General Catalyst Group V, L.P. and GC Entrepreneurs Fund V, L.P. Each of the reporting persons and entities disclaims beneficial ownership of the reported securities except to the extent of such person's or entity's pecuniary interest in such securities. |
| Performance RightsSEC Table II · derivative / convertible security | IndirectBy GC Entrepreneurs Fund IV, L.P. | Not disclosed |
Reported balance
Holding disclosure · report date 2021-07-16 · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · Balance Not disclosed F6: Each performance right represents a contingent right to receive one share of the Issuer's Class A common stock. Pursuant to an "Earn Out" provision in the Merger Agreement, the performance rights vest upon the Issuer's Class A Common stock achieving a specified price per share as follows: (i) 1/3 of the shares shall be issued if the closing sale price of Class A common stock equals or exceeds $12.50 per share for any period of 20 trading days out of 30 consecutive trading days prior to March 5, 2026; (ii) 1/3 of the shares shall be issued if the closing sale price of Class A common stock equals or exceeds $15.00 per share for any period of 20 trading days out of 30 consecutive trading days prior to March 5, 2026; and (iii) 1/3 of the shares shall be issued if the closing sale price of Class A common stock equals or exceeds $17.50 per share for any period of 20 trading days out of 30 consecutive trading days prior to March 5, 2026. F3: The reported securities are held directly by GC Entrepreneurs Fund V, L.P. General Catalyst GP V, LLC is the general partner of General Catalyst Partners V, L.P., which is the general partner of General Catalyst Group V, L.P. and GC Entrepreneurs Fund V, L.P. Lawrence Bohn, a member of Issuer's board of directors, Joel Cutler, and David Fialkow are managing directors of General Catalyst GP V, LLC, and, as a result, may be deemed to have voting and dispositive power over the shares held by General Catalyst Group V, L.P. and GC Entrepreneurs Fund V, L.P. Each of the reporting persons and entities disclaims beneficial ownership of the reported securities except to the extent of such person's or entity's pecuniary interest in such securities. |
| Performance RightsSEC Table II · derivative / convertible security | IndirectBy General Catalyst Group V, Supplemental, L.P. | Not disclosed |
Reported balance
Holding disclosure · report date 2021-07-16 · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · Balance Not disclosed F6: Each performance right represents a contingent right to receive one share of the Issuer's Class A common stock. Pursuant to an "Earn Out" provision in the Merger Agreement, the performance rights vest upon the Issuer's Class A Common stock achieving a specified price per share as follows: (i) 1/3 of the shares shall be issued if the closing sale price of Class A common stock equals or exceeds $12.50 per share for any period of 20 trading days out of 30 consecutive trading days prior to March 5, 2026; (ii) 1/3 of the shares shall be issued if the closing sale price of Class A common stock equals or exceeds $15.00 per share for any period of 20 trading days out of 30 consecutive trading days prior to March 5, 2026; and (iii) 1/3 of the shares shall be issued if the closing sale price of Class A common stock equals or exceeds $17.50 per share for any period of 20 trading days out of 30 consecutive trading days prior to March 5, 2026. F4: The reported securities are held directly by General Catalyst Group V Supplemental, L.P. General Catalyst GP V, LLC is the general partner of General Catalyst Partners V, L.P., which is the general partner of General Catalyst Group V, L.P., GC Entrepreneurs Fund V, L.P. and General Catalyst Group V Supplemental, L.P. Lawrence Bohn, a member of Issuer's board of directors, Joel Cutler, and David Fialkow are managing directors of General Catalyst GP V, LLC, and, as a result, may be deemed to have voting and dispositive power over the shares held by General Catalyst Group V, L.P., GC Entrepreneurs Fund V, L.P., and General Catalyst Group V Supplemental, L.P. GCGM Investment Holdings, L.P. is a limited partner of General Catalyst Partners V, L.P. with a pecuniary interest in the reported securities. F5: (Continued from Footnote 5) GC Partners Holdings, L.P. is a limited partner of GCGM Investment Holdings, L.P. with a pecuniary interest in the reported securities. Each of the reporting persons and entities disclaims beneficial ownership of the reported securities except to the extent of such person's or entity's pecuniary interest in such securities |
Filing footnotes · ownership attribution and instrument terms
F1: The Reporting Person acquired a portion of these securities on July 16, 2021 as consideration and in exchange for the Reporting Person's holdings in Evolv Technologies, Inc. ("Old Evolv") pursuant to an Agreement and Plan of Merger dated March 5, 2021, by and among Old Evolv, NewHold Investments Corp. (the predecessor to Issuer) and NHIC Sub Inc., as amended by that certain First Amendment to Agreement and Plan of Merger dated June 5, 2021 (as so amended, the "Merger Agreement") and the other portion of these securities on July 16, 2021, pursuant to that certain Noteholders' Consent dated June 21, 2021, by and among the noteholders identified therein, NewHold Investments Corp. and Old Evolv, entered into in connection with the Merger Agreement.
F2: The reported securities are held directly by General Catalyst Group V, L.P. General Catalyst GP V, LLC is the general partner of General Catalyst Partners V, L.P., which is the general partner of General Catalyst Group V, L.P. and GC Entrepreneurs Fund V, L.P. Lawrence Bohn, a member of Issuer's board of directors, Joel Cutler, and David Fialkow are managing directors of General Catalyst GP V, LLC, and, as a result, may be deemed to have voting and dispositive power over the shares held by General Catalyst Group V, L.P. and GC Entrepreneurs Fund V, L.P. Each of the reporting persons and entities disclaims beneficial ownership of the reported securities except to the extent of such person's or entity's pecuniary interest in such securities.
F3: The reported securities are held directly by GC Entrepreneurs Fund V, L.P. General Catalyst GP V, LLC is the general partner of General Catalyst Partners V, L.P., which is the general partner of General Catalyst Group V, L.P. and GC Entrepreneurs Fund V, L.P. Lawrence Bohn, a member of Issuer's board of directors, Joel Cutler, and David Fialkow are managing directors of General Catalyst GP V, LLC, and, as a result, may be deemed to have voting and dispositive power over the shares held by General Catalyst Group V, L.P. and GC Entrepreneurs Fund V, L.P. Each of the reporting persons and entities disclaims beneficial ownership of the reported securities except to the extent of such person's or entity's pecuniary interest in such securities.
F4: The reported securities are held directly by General Catalyst Group V Supplemental, L.P. General Catalyst GP V, LLC is the general partner of General Catalyst Partners V, L.P., which is the general partner of General Catalyst Group V, L.P., GC Entrepreneurs Fund V, L.P. and General Catalyst Group V Supplemental, L.P. Lawrence Bohn, a member of Issuer's board of directors, Joel Cutler, and David Fialkow are managing directors of General Catalyst GP V, LLC, and, as a result, may be deemed to have voting and dispositive power over the shares held by General Catalyst Group V, L.P., GC Entrepreneurs Fund V, L.P., and General Catalyst Group V Supplemental, L.P. GCGM Investment Holdings, L.P. is a limited partner of General Catalyst Partners V, L.P. with a pecuniary interest in the reported securities.
F5: (Continued from Footnote 5) GC Partners Holdings, L.P. is a limited partner of GCGM Investment Holdings, L.P. with a pecuniary interest in the reported securities. Each of the reporting persons and entities disclaims beneficial ownership of the reported securities except to the extent of such person's or entity's pecuniary interest in such securities
F6: Each performance right represents a contingent right to receive one share of the Issuer's Class A common stock. Pursuant to an "Earn Out" provision in the Merger Agreement, the performance rights vest upon the Issuer's Class A Common stock achieving a specified price per share as follows: (i) 1/3 of the shares shall be issued if the closing sale price of Class A common stock equals or exceeds $12.50 per share for any period of 20 trading days out of 30 consecutive trading days prior to March 5, 2026; (ii) 1/3 of the shares shall be issued if the closing sale price of Class A common stock equals or exceeds $15.00 per share for any period of 20 trading days out of 30 consecutive trading days prior to March 5, 2026; and (iii) 1/3 of the shares shall be issued if the closing sale price of Class A common stock equals or exceeds $17.50 per share for any period of 20 trading days out of 30 consecutive trading days prior to March 5, 2026.
General Catalyst Global Resilience Merger Corp.
Report date April 29, 2026 · Filed April 30, 2026
This filing explicitly reported no securities owned.
Health Assurance Acquisition Corp.
Report date November 12, 2020 · Filed November 13, 2020
This filing explicitly reported no securities owned.
Oscar Health, Inc.
Report date March 03, 2021 · Filed March 04, 2021
Jointly reported with General Catalyst Group Management, LLC, General Catalyst Group Management Holdings, L.P., General Catalyst Group Management Holdings GP, LLC, CHENAULT KENNETH I, Fialkow David P
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | IndirectDirectly held by General Catalyst Group VI, L.P. | 12,357,276 |
Reported balance
Holding disclosure · report date 2021-03-03 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 12,357,276 F1: General Catalyst GP VI, LLC ("GP VI, LLC") is the general partner of General Catalyst Partners VI, L.P. ("GP VI LP"), which is the general partner of General Catalyst Group VI, L.P. ("GC Group VI LP"). General Catalyst GP X - Growth Venture, LLC ("GP X, LLC") is the general partner of General Catalyst Partners X - Growth Venture, L.P., which is the general partner of General Catalyst Group X - Growth Venture, L.P. ("GC Group X Growth"). General Catalyst Group Management Holdings GP, LLC ("GCGMH LLC") is the general partner of General Catalyst Group Management Holdings, L.P. ("GCGMH"), which is the manager of General Catalyst Group Management, LLC ("GCGM"), which is the manager of GP VI, LLC and GP X, LLC. F2: (Continued from Footnote 1) Each of Kenneth Chenault, Joel Cutler, David Fialkow, and Hemant Taneja is a managing member of GCGMH LLC and shares voting and investment power over the shares held by GC Group VI LP and GC Group X Growth. Each of the foregoing entities and funds disclaims beneficial ownership of the shares held of record by GC Group VI LP and GC Group X Growth, except to the extent of their pecuniary interest therein. F3: However, each Reporting Person disclaims beneficial ownership over such shares except to the extent of his or its pecuniary interest therein, if any. A Form 3 is being filed separately by Mr. Cutler in his capacity as a director of the Issuer. |
| Class A Common StockSEC Table I · non-derivative | IndirectDirectly held by General Catalyst Group X - Growth Venture, L.P. | 2,107,719 |
Reported balance
Holding disclosure · report date 2021-03-03 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 2,107,719 F1: General Catalyst GP VI, LLC ("GP VI, LLC") is the general partner of General Catalyst Partners VI, L.P. ("GP VI LP"), which is the general partner of General Catalyst Group VI, L.P. ("GC Group VI LP"). General Catalyst GP X - Growth Venture, LLC ("GP X, LLC") is the general partner of General Catalyst Partners X - Growth Venture, L.P., which is the general partner of General Catalyst Group X - Growth Venture, L.P. ("GC Group X Growth"). General Catalyst Group Management Holdings GP, LLC ("GCGMH LLC") is the general partner of General Catalyst Group Management Holdings, L.P. ("GCGMH"), which is the manager of General Catalyst Group Management, LLC ("GCGM"), which is the manager of GP VI, LLC and GP X, LLC. F2: (Continued from Footnote 1) Each of Kenneth Chenault, Joel Cutler, David Fialkow, and Hemant Taneja is a managing member of GCGMH LLC and shares voting and investment power over the shares held by GC Group VI LP and GC Group X Growth. Each of the foregoing entities and funds disclaims beneficial ownership of the shares held of record by GC Group VI LP and GC Group X Growth, except to the extent of their pecuniary interest therein. F3: However, each Reporting Person disclaims beneficial ownership over such shares except to the extent of his or its pecuniary interest therein, if any. A Form 3 is being filed separately by Mr. Cutler in his capacity as a director of the Issuer. |
Filing footnotes · ownership attribution and instrument terms
F1: General Catalyst GP VI, LLC ("GP VI, LLC") is the general partner of General Catalyst Partners VI, L.P. ("GP VI LP"), which is the general partner of General Catalyst Group VI, L.P. ("GC Group VI LP"). General Catalyst GP X - Growth Venture, LLC ("GP X, LLC") is the general partner of General Catalyst Partners X - Growth Venture, L.P., which is the general partner of General Catalyst Group X - Growth Venture, L.P. ("GC Group X Growth"). General Catalyst Group Management Holdings GP, LLC ("GCGMH LLC") is the general partner of General Catalyst Group Management Holdings, L.P. ("GCGMH"), which is the manager of General Catalyst Group Management, LLC ("GCGM"), which is the manager of GP VI, LLC and GP X, LLC.
F2: (Continued from Footnote 1) Each of Kenneth Chenault, Joel Cutler, David Fialkow, and Hemant Taneja is a managing member of GCGMH LLC and shares voting and investment power over the shares held by GC Group VI LP and GC Group X Growth. Each of the foregoing entities and funds disclaims beneficial ownership of the shares held of record by GC Group VI LP and GC Group X Growth, except to the extent of their pecuniary interest therein.
F3: However, each Reporting Person disclaims beneficial ownership over such shares except to the extent of his or its pecuniary interest therein, if any. A Form 3 is being filed separately by Mr. Cutler in his capacity as a director of the Issuer.
Revolution Healthcare Acquisition Corp.
Report date March 17, 2021 · Filed March 17, 2021
This filing explicitly reported no securities owned.
Samsara Inc.
Report date March 22, 2024 · Filed March 26, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | IndirectDirectly held by GCGM Investment Holdings, LP | 0 |
Reported balance
After 2024-03-22 transaction · row 1
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 1 · 2024-03-22 · Sale · Disposed 68,904 · Balance 0 F1: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $36.64 to $37.17, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote of this Form 4. F2: General Catalyst Group Management Holdings GP, LLC ("GCGMH LLC") is the general partner of GCGM Investment Holdings, LP ("GCGM IH") and General Catalyst Group Management Holdings, L.P. ("GCGMH"), which is the manager of General Catalyst Group Management, LLC ("GCGM LLC"), which is (a) the manager of GC Venture VIII Manager, LLC ("GCVVIII Manager"), which is the manager of GC Venture VIII, LLC ("GCVVIII"), (b) the manager of GC Venture VIII-B Manager, LLC, which is the manager of GC Venture VIII-B, LLC ("GCVVIIIB"), (c) the manager of General Catalyst GP VIII, LLC ("GCGPVIII"), which is the general partner of General Catalyst Partners VIII, L.P. ("GCPVIII"), which is the general partner of General Catalyst Group VIII, L.P. ("GCGVIII"), F3: (Continued from Footnote 2) GCSE VIII, L.P. ("GCSE") and (d) the manager of General Catalyst GP X - Growth Venture, LLC, which is the general partner of General Catalyst Partners X - Growth Venture, L.P., which is the general partner of General Catalyst Group X - Endurance, L.P. ("GCGXE"). F4: (Continued from Footnote 3) The Reporting Person is a managing member of GCGMH LLC and a director of the Issuer. Each party named above disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein. |
| Class A Common StockSEC Table I · non-derivative | IndirectDirectly held by the Hemant Taneja and Jessica Schantz Taneja Revocable Trust, dated 4/19/12 | 670,672 |
Reported balance
Holding disclosure · report date 2024-03-22 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 670,672 |
| Class A Common StockSEC Table I · non-derivative | IndirectDirectly held by the Taneja Heritage Trust | 47,826 |
Reported balance
Holding disclosure · report date 2024-03-22 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 47,826 |
| Class A Common StockSEC Table I · non-derivative | IndirectDirectly held by General Catalyst Group XI - Endurance, L.P. | 2,000,000 |
Reported balance
Holding disclosure · report date 2024-03-22 · row 4
Holding and transaction disclosures are not merged.
1 source rowRow 4 · Balance 2,000,000 F5: GCGMH LLC is the general partner of GCGMH, which is the manager of GCGM LLC, which is the manager of General Catalyst Endurance GP XI, LLC, which is the general partner of General Catalyst Partners XI - Endurance, L.P., which is the general partner of General Catalyst Group XI - Endurance, L.P. ("GCGXIE"). The Reporting Person is a managing member of GCGMH LLC. Each party named above disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein. |
| Class B Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | IndirectDirectly held by General Catalyst Group VIII, L.P. | 11,187,815 |
Reported balance
Holding disclosure · report date 2024-03-22 · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · Balance 11,187,815 F6: The Class B Common Stock is convertible at any time, at the holder's election, into Class A Common Stock on a 1:1 basis. |
| Class B Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | IndirectDirectly held by GC Venture VIII-B, LLC | 8,588,813 |
Reported balance
Holding disclosure · report date 2024-03-22 · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · Balance 8,588,813 F6: The Class B Common Stock is convertible at any time, at the holder's election, into Class A Common Stock on a 1:1 basis. |
| Class B Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | IndirectDirectly held by General Catalyst Group X - Endurance, L.P. | 4,520,428 |
Reported balance
Holding disclosure · report date 2024-03-22 · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · Balance 4,520,428 F6: The Class B Common Stock is convertible at any time, at the holder's election, into Class A Common Stock on a 1:1 basis. |
Filing footnotes · ownership attribution and instrument terms
F1: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $36.64 to $37.17, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote of this Form 4.
F2: General Catalyst Group Management Holdings GP, LLC ("GCGMH LLC") is the general partner of GCGM Investment Holdings, LP ("GCGM IH") and General Catalyst Group Management Holdings, L.P. ("GCGMH"), which is the manager of General Catalyst Group Management, LLC ("GCGM LLC"), which is (a) the manager of GC Venture VIII Manager, LLC ("GCVVIII Manager"), which is the manager of GC Venture VIII, LLC ("GCVVIII"), (b) the manager of GC Venture VIII-B Manager, LLC, which is the manager of GC Venture VIII-B, LLC ("GCVVIIIB"), (c) the manager of General Catalyst GP VIII, LLC ("GCGPVIII"), which is the general partner of General Catalyst Partners VIII, L.P. ("GCPVIII"), which is the general partner of General Catalyst Group VIII, L.P. ("GCGVIII"),
F3: (Continued from Footnote 2) GCSE VIII, L.P. ("GCSE") and (d) the manager of General Catalyst GP X - Growth Venture, LLC, which is the general partner of General Catalyst Partners X - Growth Venture, L.P., which is the general partner of General Catalyst Group X - Endurance, L.P. ("GCGXE").
F4: (Continued from Footnote 3) The Reporting Person is a managing member of GCGMH LLC and a director of the Issuer. Each party named above disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein.
F5: GCGMH LLC is the general partner of GCGMH, which is the manager of GCGM LLC, which is the manager of General Catalyst Endurance GP XI, LLC, which is the general partner of General Catalyst Partners XI - Endurance, L.P., which is the general partner of General Catalyst Group XI - Endurance, L.P. ("GCGXIE"). The Reporting Person is a managing member of GCGMH LLC. Each party named above disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein.
F6: The Class B Common Stock is convertible at any time, at the holder's election, into Class A Common Stock on a 1:1 basis.
Teladoc Health, Inc.
Report date April 19, 2021 · Filed April 22, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 118,760 |
Ending reported balance
After 2021-04-19 transaction · row 10
10 source rows · reconciled sequenceRow 1 · 2021-04-19 · Sale · Disposed 1,200 · Balance 142,560 F1: These transactions were effected pursuant to a Rule 10b5-1 trading plan. F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $181.04 to $182.00, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) through (11) of this Form 4. Row 2 · 2021-04-19 · Sale · Disposed 8,266 · Balance 134,294 F1: These transactions were effected pursuant to a Rule 10b5-1 trading plan. F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $182.05 to $183.03, inclusive. Row 3 · 2021-04-19 · Sale · Disposed 3,000 · Balance 131,294 F1: These transactions were effected pursuant to a Rule 10b5-1 trading plan. F4: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $183.06 to $183.97, inclusive. Row 4 · 2021-04-19 · Sale · Disposed 1,900 · Balance 129,394 F1: These transactions were effected pursuant to a Rule 10b5-1 trading plan. F5: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $184.13 to $184.99, inclusive. Row 5 · 2021-04-19 · Sale · Disposed 900 · Balance 128,494 F1: These transactions were effected pursuant to a Rule 10b5-1 trading plan. F6: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $185.24 to $186.13, inclusive. Row 6 · 2021-04-19 · Sale · Disposed 1,100 · Balance 127,394 F1: These transactions were effected pursuant to a Rule 10b5-1 trading plan. F7: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $186.32 to $187.17, inclusive. Row 7 · 2021-04-19 · Sale · Disposed 1,934 · Balance 125,460 F1: These transactions were effected pursuant to a Rule 10b5-1 trading plan. F8: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $187.32 to $188.28, inclusive. Row 8 · 2021-04-19 · Sale · Disposed 2,122 · Balance 123,338 F1: These transactions were effected pursuant to a Rule 10b5-1 trading plan. F9: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $188.43 to $189.39, inclusive. Row 9 · 2021-04-19 · Sale · Disposed 4,278 · Balance 119,060 F1: These transactions were effected pursuant to a Rule 10b5-1 trading plan. F10: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $189.42 to $190.37, inclusive. Row 10 · 2021-04-19 · Sale · Disposed 300 · Balance 118,760 F1: These transactions were effected pursuant to a Rule 10b5-1 trading plan. F11: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $190.50 to $190.80, inclusive. |
| Common StockSEC Table I · non-derivative | IndirectSee footnote | 5,256,977 |
Reported balance
Holding disclosure · report date 2021-04-19 · row 11
Holding and transaction disclosures are not merged.
1 source rowRow 11 · Balance 5,256,977 F12: The shares are held of record by General Catalyst Group VI, L.P., or GC Group VI LP. General Catalyst GP VI, LLC, or GP VI LLC, is the general partner of General Catalyst Partners VI, L.P., which is the general partner of GC Group VI LP. General Catalyst Group Management Holdings, L.P., or GCGMH, is the manager of General Catalyst Group Management, LLC, or GCGM, which is the manager of GP VI LLC. As a Managing Member of General Catalyst Group Management Holdings GP, LLC, or GCGMH LLC, the general partner of GCGMH, the reporting person shares voting and investment power with respect to shares held by GC Group VI LP. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest in such securities. |
| Common StockSEC Table I · non-derivative | IndirectSee footnote | 373,361 |
Reported balance
Holding disclosure · report date 2021-04-19 · row 12
Holding and transaction disclosures are not merged.
1 source rowRow 12 · Balance 373,361 F13: 10,616 shares are held by 7wire Investment Holdings, Ltd., or 7wire, which is wholly owned by General Catalyst Group VIII, L.P., or GC Group VIII LP, and the balance are held by GC Group VIII LP. General Catalyst GP VIII, LLC, or GP VIII LLC, is the general partner of General Catalyst Partners VIII, L.P., or GP VIII LP, which is the general partner of GC Group VIII LP. GCGM, is the manager of GP VIII LLC. GCGMH, is the manager of GCGM. As a Managing Member of GCGMH LLC, the general partner of GCGMH, the reporting person shares voting and investment power with respect to shares held by 7wire and GC Group VIII LP. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest in such securities. |
| Common StockSEC Table I · non-derivative | IndirectSee footnote | 1,090,622 |
Reported balance
Holding disclosure · report date 2021-04-19 · row 13
Holding and transaction disclosures are not merged.
1 source rowRow 13 · Balance 1,090,622 F14: The shares are held of record by General Catalyst Group VIII Supplemental, L.P., or GC Group VIII Supplemental. GP VIII LLC is the general partner of GP VIII LP, which is the general partner of GC Group VIII Supplemental. GCGMH is the manager of GCGM, which is the manager of GP VIII LLC. As a Managing Member of GCGMH LLC, the general partner of GCGMH, the reporting person shares voting and investment power with respect to shares held by GC Group VIII Supplemental. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest in such securities. |
| Common StockSEC Table I · non-derivative | IndirectSee footnote | 3,391 |
Reported balance
Holding disclosure · report date 2021-04-19 · row 14
Holding and transaction disclosures are not merged.
1 source rowRow 14 · Balance 3,391 F15: These shares are held of record by GCGM Investment Holdings, LP, or GCGM IH. As a Managing Member of GCGMH LLC, the general partner of GCGM IH, the reporting person shares voting and investment power with respect to shares held by GCGM IH. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest in such securities. |
Filing footnotes · ownership attribution and instrument terms
F1: These transactions were effected pursuant to a Rule 10b5-1 trading plan.
F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $181.04 to $182.00, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) through (11) of this Form 4.
F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $182.05 to $183.03, inclusive.
F4: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $183.06 to $183.97, inclusive.
F5: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $184.13 to $184.99, inclusive.
F6: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $185.24 to $186.13, inclusive.
F7: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $186.32 to $187.17, inclusive.
F8: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $187.32 to $188.28, inclusive.
F9: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $188.43 to $189.39, inclusive.
F10: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $189.42 to $190.37, inclusive.
F11: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $190.50 to $190.80, inclusive.
F12: The shares are held of record by General Catalyst Group VI, L.P., or GC Group VI LP. General Catalyst GP VI, LLC, or GP VI LLC, is the general partner of General Catalyst Partners VI, L.P., which is the general partner of GC Group VI LP. General Catalyst Group Management Holdings, L.P., or GCGMH, is the manager of General Catalyst Group Management, LLC, or GCGM, which is the manager of GP VI LLC. As a Managing Member of General Catalyst Group Management Holdings GP, LLC, or GCGMH LLC, the general partner of GCGMH, the reporting person shares voting and investment power with respect to shares held by GC Group VI LP. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest in such securities.
F13: 10,616 shares are held by 7wire Investment Holdings, Ltd., or 7wire, which is wholly owned by General Catalyst Group VIII, L.P., or GC Group VIII LP, and the balance are held by GC Group VIII LP. General Catalyst GP VIII, LLC, or GP VIII LLC, is the general partner of General Catalyst Partners VIII, L.P., or GP VIII LP, which is the general partner of GC Group VIII LP. GCGM, is the manager of GP VIII LLC. GCGMH, is the manager of GCGM. As a Managing Member of GCGMH LLC, the general partner of GCGMH, the reporting person shares voting and investment power with respect to shares held by 7wire and GC Group VIII LP. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest in such securities.
F14: The shares are held of record by General Catalyst Group VIII Supplemental, L.P., or GC Group VIII Supplemental. GP VIII LLC is the general partner of GP VIII LP, which is the general partner of GC Group VIII Supplemental. GCGMH is the manager of GCGM, which is the manager of GP VIII LLC. As a Managing Member of GCGMH LLC, the general partner of GCGMH, the reporting person shares voting and investment power with respect to shares held by GC Group VIII Supplemental. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest in such securities.
F15: These shares are held of record by GCGM Investment Holdings, LP, or GCGM IH. As a Managing Member of GCGMH LLC, the general partner of GCGM IH, the reporting person shares voting and investment power with respect to shares held by GCGM IH. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest in such securities.
Wag! Group Co.
Report date August 09, 2022 · Filed August 09, 2022
Jointly reported with General Catalyst Group VII, L.P., General Catalyst Partners VII, L.P., General Catalyst GP VII, LLC, General Catalyst Group Management, LLC, General Catalyst Group Management Holdings, L.P., General Catalyst Group Management Holdings GP, LLC, CHENAULT KENNETH I, Cutler Joel E, Fialkow David P
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectDirectly held by General Catalyst Group VII, L.P. | 6,976,530 |
Reported balance
Holding disclosure · report date 2022-08-09 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 6,976,530 F1: The Reporting Person acquired these securities on August 2, 2022, as consideration and in exchange for the Reporting Person's holdings in Wag Labs, Inc. ("Old Wag!") pursuant to a definitive Business Combination Agreement dated February 2, 2022, by and among CHW Acquisition Corporation (the predecessor to the Issuer), CHW Merger Sub Inc., and Old Wag!. F2: General Catalyst GP VII, LLC ("GP VII, LLC") is the general partner of General Catalyst Partners VII, L.P. ("GP VI LP"), which is the general partner of General Catalyst Group VII, L.P. ("GC Group VII LP"). General Catalyst Group Management Holdings GP, LLC ("GCGMH LLC") is the general partner of General Catalyst Group Management Holdings, L.P. ("GCGMH"), which is the manager of General Catalyst Group Management, LLC ("GCGM"), which is the manager of GP VII, LLC. Each of Kenneth Chenault, Joel Cutler, David Fialkow, and Hemant Taneja is a managing member of GCGMH LLC and shares voting and investment power over the shares held by GC Group VII LP. Each Reporting Person disclaims beneficial ownership of the shares held of record by GC Group VII LP, except to the extent of their pecuniary interest therein, if any. |
Filing footnotes · ownership attribution and instrument terms
F1: The Reporting Person acquired these securities on August 2, 2022, as consideration and in exchange for the Reporting Person's holdings in Wag Labs, Inc. ("Old Wag!") pursuant to a definitive Business Combination Agreement dated February 2, 2022, by and among CHW Acquisition Corporation (the predecessor to the Issuer), CHW Merger Sub Inc., and Old Wag!.
F2: General Catalyst GP VII, LLC ("GP VII, LLC") is the general partner of General Catalyst Partners VII, L.P. ("GP VI LP"), which is the general partner of General Catalyst Group VII, L.P. ("GC Group VII LP"). General Catalyst Group Management Holdings GP, LLC ("GCGMH LLC") is the general partner of General Catalyst Group Management Holdings, L.P. ("GCGMH"), which is the manager of General Catalyst Group Management, LLC ("GCGM"), which is the manager of GP VII, LLC. Each of Kenneth Chenault, Joel Cutler, David Fialkow, and Hemant Taneja is a managing member of GCGMH LLC and shares voting and investment power over the shares held by GC Group VII LP. Each Reporting Person disclaims beneficial ownership of the shares held of record by GC Group VII LP, except to the extent of their pecuniary interest therein, if any.
Past disclosures · reporting ended (3)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
INTERSECTIONS INC
Report date January 11, 2019 · Filed January 15, 2019
Jointly reported with General Catalyst Group IX, L.P., GC Entrepreneurs Fund IX, L.P., General Catalyst Partners IX, L.P., General Catalyst GP IX, LLC, General Catalyst Group Management, LLC, CHENAULT KENNETH I, Cutler Joel E, Fialkow David P
Section 16 reporting ended · disclosed 2019-01-15. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectSee Footnotes | 13,240,089 |
Reported balance
After 2019-01-11 transaction · row 1
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 1 · 2019-01-11 · Other · Acquired 13,240,089 · Balance 13,240,089 F1: This statement on Form 4 is being jointly filed by General Catalyst Group IX, L.P., a Delaware limited partnership ("GC IX"), GC Entrepreneurs Fund IX, L.P., a Delaware limited partnership (together with GC IX, the "GC Funds"), General Catalyst Partners IX, L.P., a Delaware limited partnership, General Catalyst GP IX, LLC, a Delaware limited liability company, General Catalyst Group Management, LLC, a Delaware limited liability company, Kenneth I. Chenault, Joel E. Cutler, David P. Fialkow and Hemant Taneja (collectively, the "Reporting Persons"), and relates to the common stock, par value $0.01 per share ("Common Stock"), of Intersections Inc., a Delaware corporation (the "Company"). The GC Funds are stockholders of a joint venture, WC SACD One, Inc., a Delaware corporation ("WC SACD"). WC SACD One Parent, Inc., a Delaware corporation ("Parent"), is a direct wholly-owned subsidiary of WC SACD. F2: (Continued from Footnote 1) Prior to the Merger (as defined below), WC SACD One Merger Sub, Inc., a Delaware corporation ("Merger Sub"), was a direct wholly-owned subsidiary of Parent. F3: On January 11, 2019, Parent completed its acquisition of the Company pursuant to the terms of that certain Agreement and Plan of Merger, dated as of October 31, 2018, as amended (the "Merger Agreement"), by and among Parent, Merger Sub and the Company, wherein Merger Sub merged with and into the Company, with the Company surviving as an indirect wholly-owned subsidiary of Parent (the "Merger"). Pursuant to the terms of the Merger Agreement, Merger Sub conducted a tender offer (the "Offer") for all issued and outstanding shares of Common Stock (other than certain shares that certain stockholders agreed to roll over in the transaction), at a price of $3.68 per share, in cash, without interest and less any applicable withholding taxes. The Offer expired on January 4, 2019 at 5 p.m. New York City time. On January 7, 2019, Merger Sub accepted for payment all shares validly tendered and not withdrawn in the Offer. F4: On January 11, 2019, immediately prior to the effective time of the Merger, the outstanding principal balance of the senior convertible note held by Parent (the "Parent Note"), together with all accrued and unpaid interest thereon, automatically converted in accordance with its terms into shares of Common Stock, at a conversion price equal to $2.27 per share. The terms of the Parent Note, which was purchased by Parent in an aggregate principal amount of $30,000,000 on October 31, 2018, provided that it would convert into shares of Common Stock or the Company's 6.0% Series A Preferred Stock, par value $0.01 per share, as applicable, pursuant to the terms of the Note Purchase and Exchange Agreement, dated as of October 31, 2018, by and among the Company, Parent and the other noteholders. F5: As of January 11, 2019, the Parent Note had $30,000,000 in outstanding principal balance and had accrued $55,000 in unpaid interest, for a total of $30,055,000. At a conversion price of $2.27 per share, the Parent Note was converted into 13,240,089 shares of Common Stock in accordance with the terms of the Parent Note (the "Note Conversion Shares"). F10: Because of the relationship among the Reporting Persons, WC SACD, Parent and Merger Sub, each of the Reporting Persons may be deemed to indirectly beneficially own shares of Common Stock beneficially owned by Parent and Merger Sub. Each of the Reporting Persons disclaims beneficial ownership of the securities reported on this Form 4, except to the extent of its or his pecuniary interest therein, and the reporting of such securities on this Form 4 shall not be construed as an admission that any of the Reporting Persons is the beneficial owner thereof for purposes of Section 16 of the Securities Exchange Act of 1934 or for any other purpose. |
| Common StockSEC Table I · non-derivative | IndirectSee Footnotes | 24,343,729 |
Reported balance
After 2019-01-11 transaction · row 2
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 2 · 2019-01-11 · Other · Acquired 11,103,640 · Balance 24,343,729 F1: This statement on Form 4 is being jointly filed by General Catalyst Group IX, L.P., a Delaware limited partnership ("GC IX"), GC Entrepreneurs Fund IX, L.P., a Delaware limited partnership (together with GC IX, the "GC Funds"), General Catalyst Partners IX, L.P., a Delaware limited partnership, General Catalyst GP IX, LLC, a Delaware limited liability company, General Catalyst Group Management, LLC, a Delaware limited liability company, Kenneth I. Chenault, Joel E. Cutler, David P. Fialkow and Hemant Taneja (collectively, the "Reporting Persons"), and relates to the common stock, par value $0.01 per share ("Common Stock"), of Intersections Inc., a Delaware corporation (the "Company"). The GC Funds are stockholders of a joint venture, WC SACD One, Inc., a Delaware corporation ("WC SACD"). WC SACD One Parent, Inc., a Delaware corporation ("Parent"), is a direct wholly-owned subsidiary of WC SACD. F2: (Continued from Footnote 1) Prior to the Merger (as defined below), WC SACD One Merger Sub, Inc., a Delaware corporation ("Merger Sub"), was a direct wholly-owned subsidiary of Parent. F6: Represents shares of Common Stock that were contributed and assigned, immediately prior to the effective time of the Merger, to WC SACD (the "Rollover Shares"), in exchange for equity interests in WC SACD, pursuant to the terms and conditions of those certain Contribution and Assignment Agreements, dated as of October 31, 2018, by and between WC SACD, on the one hand, and each of Loeb Holding Corporation, Michael Stanfield, Stanfield Family Investments LLC and David McGough, on the other hand. F7: Immediately following the contribution and assignment of the Rollover Shares to WC SACD and prior to the effective time of the Merger, WC SACD contributed and assigned the Rollover Shares to Parent. As such, Parent became the direct beneficial owner of the Rollover Shares. F10: Because of the relationship among the Reporting Persons, WC SACD, Parent and Merger Sub, each of the Reporting Persons may be deemed to indirectly beneficially own shares of Common Stock beneficially owned by Parent and Merger Sub. Each of the Reporting Persons disclaims beneficial ownership of the securities reported on this Form 4, except to the extent of its or his pecuniary interest therein, and the reporting of such securities on this Form 4 shall not be construed as an admission that any of the Reporting Persons is the beneficial owner thereof for purposes of Section 16 of the Securities Exchange Act of 1934 or for any other purpose. |
| Common StockSEC Table I · non-derivative | IndirectSee Footnotes | 37,787,129 |
Reported balance
After 2019-01-11 transaction · row 3
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 3 · 2019-01-11 · Purchase · Acquired 13,443,400 · Balance 37,787,129 F1: This statement on Form 4 is being jointly filed by General Catalyst Group IX, L.P., a Delaware limited partnership ("GC IX"), GC Entrepreneurs Fund IX, L.P., a Delaware limited partnership (together with GC IX, the "GC Funds"), General Catalyst Partners IX, L.P., a Delaware limited partnership, General Catalyst GP IX, LLC, a Delaware limited liability company, General Catalyst Group Management, LLC, a Delaware limited liability company, Kenneth I. Chenault, Joel E. Cutler, David P. Fialkow and Hemant Taneja (collectively, the "Reporting Persons"), and relates to the common stock, par value $0.01 per share ("Common Stock"), of Intersections Inc., a Delaware corporation (the "Company"). The GC Funds are stockholders of a joint venture, WC SACD One, Inc., a Delaware corporation ("WC SACD"). WC SACD One Parent, Inc., a Delaware corporation ("Parent"), is a direct wholly-owned subsidiary of WC SACD. F2: (Continued from Footnote 1) Prior to the Merger (as defined below), WC SACD One Merger Sub, Inc., a Delaware corporation ("Merger Sub"), was a direct wholly-owned subsidiary of Parent. F3: On January 11, 2019, Parent completed its acquisition of the Company pursuant to the terms of that certain Agreement and Plan of Merger, dated as of October 31, 2018, as amended (the "Merger Agreement"), by and among Parent, Merger Sub and the Company, wherein Merger Sub merged with and into the Company, with the Company surviving as an indirect wholly-owned subsidiary of Parent (the "Merger"). Pursuant to the terms of the Merger Agreement, Merger Sub conducted a tender offer (the "Offer") for all issued and outstanding shares of Common Stock (other than certain shares that certain stockholders agreed to roll over in the transaction), at a price of $3.68 per share, in cash, without interest and less any applicable withholding taxes. The Offer expired on January 4, 2019 at 5 p.m. New York City time. On January 7, 2019, Merger Sub accepted for payment all shares validly tendered and not withdrawn in the Offer. F8: Represents (i) 13,435,388 shares of Common Stock owned directly by Merger Sub (which such shares were purchased by Merger Sub on January 7, 2019 in connection with the closing of the Offer) and (ii) 8,012 shares of Common Stock that were validly delivered pursuant to notice of guaranteed delivery procedures and purchased by Merger Sub upon closing of the Offer on January 11, 2019 (the "Tender Offer Shares"). F10: Because of the relationship among the Reporting Persons, WC SACD, Parent and Merger Sub, each of the Reporting Persons may be deemed to indirectly beneficially own shares of Common Stock beneficially owned by Parent and Merger Sub. Each of the Reporting Persons disclaims beneficial ownership of the securities reported on this Form 4, except to the extent of its or his pecuniary interest therein, and the reporting of such securities on this Form 4 shall not be construed as an admission that any of the Reporting Persons is the beneficial owner thereof for purposes of Section 16 of the Securities Exchange Act of 1934 or for any other purpose. |
| Common StockSEC Table I · non-derivative | IndirectSee Footnotes | 0 |
Reported balance
After 2019-01-11 transaction · row 4
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 4 · 2019-01-11 · Other · Disposed 37,787,129 · Balance 0 F1: This statement on Form 4 is being jointly filed by General Catalyst Group IX, L.P., a Delaware limited partnership ("GC IX"), GC Entrepreneurs Fund IX, L.P., a Delaware limited partnership (together with GC IX, the "GC Funds"), General Catalyst Partners IX, L.P., a Delaware limited partnership, General Catalyst GP IX, LLC, a Delaware limited liability company, General Catalyst Group Management, LLC, a Delaware limited liability company, Kenneth I. Chenault, Joel E. Cutler, David P. Fialkow and Hemant Taneja (collectively, the "Reporting Persons"), and relates to the common stock, par value $0.01 per share ("Common Stock"), of Intersections Inc., a Delaware corporation (the "Company"). The GC Funds are stockholders of a joint venture, WC SACD One, Inc., a Delaware corporation ("WC SACD"). WC SACD One Parent, Inc., a Delaware corporation ("Parent"), is a direct wholly-owned subsidiary of WC SACD. F2: (Continued from Footnote 1) Prior to the Merger (as defined below), WC SACD One Merger Sub, Inc., a Delaware corporation ("Merger Sub"), was a direct wholly-owned subsidiary of Parent. F9: In accordance with the terms of the Merger Agreement, at the effective time of the Merger, all issued and outstanding shares of Common Stock held by Parent and Merger Sub were automatically cancelled in the Merger for no consideration. F10: Because of the relationship among the Reporting Persons, WC SACD, Parent and Merger Sub, each of the Reporting Persons may be deemed to indirectly beneficially own shares of Common Stock beneficially owned by Parent and Merger Sub. Each of the Reporting Persons disclaims beneficial ownership of the securities reported on this Form 4, except to the extent of its or his pecuniary interest therein, and the reporting of such securities on this Form 4 shall not be construed as an admission that any of the Reporting Persons is the beneficial owner thereof for purposes of Section 16 of the Securities Exchange Act of 1934 or for any other purpose. |
| Senior Convertible NoteSEC Table II · derivative / convertible security · Conversion / exercise price $2.27 · Expires 2021-10-31 | IndirectSee Footnotes | 0 |
Reported balance
After 2019-01-11 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2019-01-11 · Other · Disposed 30,055,000 · Balance 0 F3: On January 11, 2019, Parent completed its acquisition of the Company pursuant to the terms of that certain Agreement and Plan of Merger, dated as of October 31, 2018, as amended (the "Merger Agreement"), by and among Parent, Merger Sub and the Company, wherein Merger Sub merged with and into the Company, with the Company surviving as an indirect wholly-owned subsidiary of Parent (the "Merger"). Pursuant to the terms of the Merger Agreement, Merger Sub conducted a tender offer (the "Offer") for all issued and outstanding shares of Common Stock (other than certain shares that certain stockholders agreed to roll over in the transaction), at a price of $3.68 per share, in cash, without interest and less any applicable withholding taxes. The Offer expired on January 4, 2019 at 5 p.m. New York City time. On January 7, 2019, Merger Sub accepted for payment all shares validly tendered and not withdrawn in the Offer. F4: On January 11, 2019, immediately prior to the effective time of the Merger, the outstanding principal balance of the senior convertible note held by Parent (the "Parent Note"), together with all accrued and unpaid interest thereon, automatically converted in accordance with its terms into shares of Common Stock, at a conversion price equal to $2.27 per share. The terms of the Parent Note, which was purchased by Parent in an aggregate principal amount of $30,000,000 on October 31, 2018, provided that it would convert into shares of Common Stock or the Company's 6.0% Series A Preferred Stock, par value $0.01 per share, as applicable, pursuant to the terms of the Note Purchase and Exchange Agreement, dated as of October 31, 2018, by and among the Company, Parent and the other noteholders. F5: As of January 11, 2019, the Parent Note had $30,000,000 in outstanding principal balance and had accrued $55,000 in unpaid interest, for a total of $30,055,000. At a conversion price of $2.27 per share, the Parent Note was converted into 13,240,089 shares of Common Stock in accordance with the terms of the Parent Note (the "Note Conversion Shares"). F10: Because of the relationship among the Reporting Persons, WC SACD, Parent and Merger Sub, each of the Reporting Persons may be deemed to indirectly beneficially own shares of Common Stock beneficially owned by Parent and Merger Sub. Each of the Reporting Persons disclaims beneficial ownership of the securities reported on this Form 4, except to the extent of its or his pecuniary interest therein, and the reporting of such securities on this Form 4 shall not be construed as an admission that any of the Reporting Persons is the beneficial owner thereof for purposes of Section 16 of the Securities Exchange Act of 1934 or for any other purpose. F1: This statement on Form 4 is being jointly filed by General Catalyst Group IX, L.P., a Delaware limited partnership ("GC IX"), GC Entrepreneurs Fund IX, L.P., a Delaware limited partnership (together with GC IX, the "GC Funds"), General Catalyst Partners IX, L.P., a Delaware limited partnership, General Catalyst GP IX, LLC, a Delaware limited liability company, General Catalyst Group Management, LLC, a Delaware limited liability company, Kenneth I. Chenault, Joel E. Cutler, David P. Fialkow and Hemant Taneja (collectively, the "Reporting Persons"), and relates to the common stock, par value $0.01 per share ("Common Stock"), of Intersections Inc., a Delaware corporation (the "Company"). The GC Funds are stockholders of a joint venture, WC SACD One, Inc., a Delaware corporation ("WC SACD"). WC SACD One Parent, Inc., a Delaware corporation ("Parent"), is a direct wholly-owned subsidiary of WC SACD. F2: (Continued from Footnote 1) Prior to the Merger (as defined below), WC SACD One Merger Sub, Inc., a Delaware corporation ("Merger Sub"), was a direct wholly-owned subsidiary of Parent. |
Filing footnotes · ownership attribution and instrument terms
F1: This statement on Form 4 is being jointly filed by General Catalyst Group IX, L.P., a Delaware limited partnership ("GC IX"), GC Entrepreneurs Fund IX, L.P., a Delaware limited partnership (together with GC IX, the "GC Funds"), General Catalyst Partners IX, L.P., a Delaware limited partnership, General Catalyst GP IX, LLC, a Delaware limited liability company, General Catalyst Group Management, LLC, a Delaware limited liability company, Kenneth I. Chenault, Joel E. Cutler, David P. Fialkow and Hemant Taneja (collectively, the "Reporting Persons"), and relates to the common stock, par value $0.01 per share ("Common Stock"), of Intersections Inc., a Delaware corporation (the "Company"). The GC Funds are stockholders of a joint venture, WC SACD One, Inc., a Delaware corporation ("WC SACD"). WC SACD One Parent, Inc., a Delaware corporation ("Parent"), is a direct wholly-owned subsidiary of WC SACD.
F2: (Continued from Footnote 1) Prior to the Merger (as defined below), WC SACD One Merger Sub, Inc., a Delaware corporation ("Merger Sub"), was a direct wholly-owned subsidiary of Parent.
F3: On January 11, 2019, Parent completed its acquisition of the Company pursuant to the terms of that certain Agreement and Plan of Merger, dated as of October 31, 2018, as amended (the "Merger Agreement"), by and among Parent, Merger Sub and the Company, wherein Merger Sub merged with and into the Company, with the Company surviving as an indirect wholly-owned subsidiary of Parent (the "Merger"). Pursuant to the terms of the Merger Agreement, Merger Sub conducted a tender offer (the "Offer") for all issued and outstanding shares of Common Stock (other than certain shares that certain stockholders agreed to roll over in the transaction), at a price of $3.68 per share, in cash, without interest and less any applicable withholding taxes. The Offer expired on January 4, 2019 at 5 p.m. New York City time. On January 7, 2019, Merger Sub accepted for payment all shares validly tendered and not withdrawn in the Offer.
F4: On January 11, 2019, immediately prior to the effective time of the Merger, the outstanding principal balance of the senior convertible note held by Parent (the "Parent Note"), together with all accrued and unpaid interest thereon, automatically converted in accordance with its terms into shares of Common Stock, at a conversion price equal to $2.27 per share. The terms of the Parent Note, which was purchased by Parent in an aggregate principal amount of $30,000,000 on October 31, 2018, provided that it would convert into shares of Common Stock or the Company's 6.0% Series A Preferred Stock, par value $0.01 per share, as applicable, pursuant to the terms of the Note Purchase and Exchange Agreement, dated as of October 31, 2018, by and among the Company, Parent and the other noteholders.
F5: As of January 11, 2019, the Parent Note had $30,000,000 in outstanding principal balance and had accrued $55,000 in unpaid interest, for a total of $30,055,000. At a conversion price of $2.27 per share, the Parent Note was converted into 13,240,089 shares of Common Stock in accordance with the terms of the Parent Note (the "Note Conversion Shares").
F6: Represents shares of Common Stock that were contributed and assigned, immediately prior to the effective time of the Merger, to WC SACD (the "Rollover Shares"), in exchange for equity interests in WC SACD, pursuant to the terms and conditions of those certain Contribution and Assignment Agreements, dated as of October 31, 2018, by and between WC SACD, on the one hand, and each of Loeb Holding Corporation, Michael Stanfield, Stanfield Family Investments LLC and David McGough, on the other hand.
F7: Immediately following the contribution and assignment of the Rollover Shares to WC SACD and prior to the effective time of the Merger, WC SACD contributed and assigned the Rollover Shares to Parent. As such, Parent became the direct beneficial owner of the Rollover Shares.
F8: Represents (i) 13,435,388 shares of Common Stock owned directly by Merger Sub (which such shares were purchased by Merger Sub on January 7, 2019 in connection with the closing of the Offer) and (ii) 8,012 shares of Common Stock that were validly delivered pursuant to notice of guaranteed delivery procedures and purchased by Merger Sub upon closing of the Offer on January 11, 2019 (the "Tender Offer Shares").
F9: In accordance with the terms of the Merger Agreement, at the effective time of the Merger, all issued and outstanding shares of Common Stock held by Parent and Merger Sub were automatically cancelled in the Merger for no consideration.
F10: Because of the relationship among the Reporting Persons, WC SACD, Parent and Merger Sub, each of the Reporting Persons may be deemed to indirectly beneficially own shares of Common Stock beneficially owned by Parent and Merger Sub. Each of the Reporting Persons disclaims beneficial ownership of the securities reported on this Form 4, except to the extent of its or his pecuniary interest therein, and the reporting of such securities on this Form 4 shall not be construed as an admission that any of the Reporting Persons is the beneficial owner thereof for purposes of Section 16 of the Securities Exchange Act of 1934 or for any other purpose.
Lemonade, Inc.
Report date July 07, 2020 · Filed July 08, 2020
Jointly reported with General Catalyst Group Management Holdings GP, LLC, General Catalyst Group Management Holdings, L.P., General Catalyst Group Management, LLC, General Catalyst GP VIII, LLC, General Catalyst Partners VIII, L.P., General Catalyst Group VIII, L.P., General Catalyst Group VIII Supplemental, L.P., CHENAULT KENNETH I, Fialkow David P
Section 16 reporting ended · disclosed 2020-07-08. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectDirectly held by General Catalyst Group VIII, L.P. | 1,492,691 |
Reported balance
After 2020-07-07 transaction · row 1
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 1 · 2020-07-07 · Conversion · Acquired 1,492,691 · Balance 1,492,691 F1: Upon the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into shares of the Issuer's common stock on a one-for-one basis. F2: General Catalyst GP VIII, LLC ("GC VIII LLC") is the general partner of General Catalyst Partners VIII, L.P. ("GC VIII LP"), which is the general partner of General Catalyst Group VIII, L.P. ("CG Group VIII") and General Catalyst Group VIII Supplemental, L.P. ("CG Group VIII Supplemental"). General Catalyst Group Management, LLC ("GCGM") is the manager of GC VIII LLC. General Catalyst Group Management Holdings, L.P. ("GCGMH") is the manager of GCGM. F3: General Catalyst Group Management Holdings GP, LLC ("GCGMH LLC") is the general partner of GCGMH. Each of Kenneth Chenault, Joel Cutler, David Fialkow, and Hemant Taneja is a managing director of GCGMH LLC and shares voting and investment power over the shares held by GC Group VIII and GC Group VIII Supplemental. However, each Reporting Person disclaims beneficial ownership over such shares except to the extent of his or its pecuniary interest therein, if any. A Form 4 is being filed separately by Mr. Cutler in his capacity as a director of the Issuer. |
| Common StockSEC Table I · non-derivative | IndirectDirectly held by General Catalyst Group VIII Supplemental, L.P. | 1,729,622 |
Reported balance
After 2020-07-07 transaction · row 2
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 2 · 2020-07-07 · Conversion · Acquired 1,729,622 · Balance 1,729,622 F1: Upon the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into shares of the Issuer's common stock on a one-for-one basis. F2: General Catalyst GP VIII, LLC ("GC VIII LLC") is the general partner of General Catalyst Partners VIII, L.P. ("GC VIII LP"), which is the general partner of General Catalyst Group VIII, L.P. ("CG Group VIII") and General Catalyst Group VIII Supplemental, L.P. ("CG Group VIII Supplemental"). General Catalyst Group Management, LLC ("GCGM") is the manager of GC VIII LLC. General Catalyst Group Management Holdings, L.P. ("GCGMH") is the manager of GCGM. F3: General Catalyst Group Management Holdings GP, LLC ("GCGMH LLC") is the general partner of GCGMH. Each of Kenneth Chenault, Joel Cutler, David Fialkow, and Hemant Taneja is a managing director of GCGMH LLC and shares voting and investment power over the shares held by GC Group VIII and GC Group VIII Supplemental. However, each Reporting Person disclaims beneficial ownership over such shares except to the extent of his or its pecuniary interest therein, if any. A Form 4 is being filed separately by Mr. Cutler in his capacity as a director of the Issuer. |
| Series B Preferred StockSEC Table II · derivative / convertible security | IndirectDirectly held by General Catalyst Group VIII, L.P. | 0 |
Reported balance
After 2020-07-07 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2020-07-07 · Conversion · Disposed 1,157,621 · Balance 0 F1: Upon the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into shares of the Issuer's common stock on a one-for-one basis. F2: General Catalyst GP VIII, LLC ("GC VIII LLC") is the general partner of General Catalyst Partners VIII, L.P. ("GC VIII LP"), which is the general partner of General Catalyst Group VIII, L.P. ("CG Group VIII") and General Catalyst Group VIII Supplemental, L.P. ("CG Group VIII Supplemental"). General Catalyst Group Management, LLC ("GCGM") is the manager of GC VIII LLC. General Catalyst Group Management Holdings, L.P. ("GCGMH") is the manager of GCGM. F3: General Catalyst Group Management Holdings GP, LLC ("GCGMH LLC") is the general partner of GCGMH. Each of Kenneth Chenault, Joel Cutler, David Fialkow, and Hemant Taneja is a managing director of GCGMH LLC and shares voting and investment power over the shares held by GC Group VIII and GC Group VIII Supplemental. However, each Reporting Person disclaims beneficial ownership over such shares except to the extent of his or its pecuniary interest therein, if any. A Form 4 is being filed separately by Mr. Cutler in his capacity as a director of the Issuer. |
| Series B Preferred StockSEC Table II · derivative / convertible security | IndirectDirectly held by General Catalyst Group VIII Supplemental, L.P. | 0 |
Reported balance
After 2020-07-07 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2020-07-07 · Conversion · Disposed 1,157,621 · Balance 0 F1: Upon the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into shares of the Issuer's common stock on a one-for-one basis. F2: General Catalyst GP VIII, LLC ("GC VIII LLC") is the general partner of General Catalyst Partners VIII, L.P. ("GC VIII LP"), which is the general partner of General Catalyst Group VIII, L.P. ("CG Group VIII") and General Catalyst Group VIII Supplemental, L.P. ("CG Group VIII Supplemental"). General Catalyst Group Management, LLC ("GCGM") is the manager of GC VIII LLC. General Catalyst Group Management Holdings, L.P. ("GCGMH") is the manager of GCGM. F3: General Catalyst Group Management Holdings GP, LLC ("GCGMH LLC") is the general partner of GCGMH. Each of Kenneth Chenault, Joel Cutler, David Fialkow, and Hemant Taneja is a managing director of GCGMH LLC and shares voting and investment power over the shares held by GC Group VIII and GC Group VIII Supplemental. However, each Reporting Person disclaims beneficial ownership over such shares except to the extent of his or its pecuniary interest therein, if any. A Form 4 is being filed separately by Mr. Cutler in his capacity as a director of the Issuer. |
| Series C Preferred StockSEC Table II · derivative / convertible security | IndirectDirectly held by General Catalyst Group VIII, L.P. | 0 |
Reported balance
After 2020-07-07 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2020-07-07 · Conversion · Disposed 335,070 · Balance 0 F1: Upon the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into shares of the Issuer's common stock on a one-for-one basis. F2: General Catalyst GP VIII, LLC ("GC VIII LLC") is the general partner of General Catalyst Partners VIII, L.P. ("GC VIII LP"), which is the general partner of General Catalyst Group VIII, L.P. ("CG Group VIII") and General Catalyst Group VIII Supplemental, L.P. ("CG Group VIII Supplemental"). General Catalyst Group Management, LLC ("GCGM") is the manager of GC VIII LLC. General Catalyst Group Management Holdings, L.P. ("GCGMH") is the manager of GCGM. F3: General Catalyst Group Management Holdings GP, LLC ("GCGMH LLC") is the general partner of GCGMH. Each of Kenneth Chenault, Joel Cutler, David Fialkow, and Hemant Taneja is a managing director of GCGMH LLC and shares voting and investment power over the shares held by GC Group VIII and GC Group VIII Supplemental. However, each Reporting Person disclaims beneficial ownership over such shares except to the extent of his or its pecuniary interest therein, if any. A Form 4 is being filed separately by Mr. Cutler in his capacity as a director of the Issuer. |
| Series C Preferred StockSEC Table II · derivative / convertible security | IndirectDirectly held by General Catalyst Group VIII Supplemental, L.P. | 0 |
Reported balance
After 2020-07-07 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2020-07-07 · Conversion · Disposed 335,070 · Balance 0 F1: Upon the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into shares of the Issuer's common stock on a one-for-one basis. F2: General Catalyst GP VIII, LLC ("GC VIII LLC") is the general partner of General Catalyst Partners VIII, L.P. ("GC VIII LP"), which is the general partner of General Catalyst Group VIII, L.P. ("CG Group VIII") and General Catalyst Group VIII Supplemental, L.P. ("CG Group VIII Supplemental"). General Catalyst Group Management, LLC ("GCGM") is the manager of GC VIII LLC. General Catalyst Group Management Holdings, L.P. ("GCGMH") is the manager of GCGM. F3: General Catalyst Group Management Holdings GP, LLC ("GCGMH LLC") is the general partner of GCGMH. Each of Kenneth Chenault, Joel Cutler, David Fialkow, and Hemant Taneja is a managing director of GCGMH LLC and shares voting and investment power over the shares held by GC Group VIII and GC Group VIII Supplemental. However, each Reporting Person disclaims beneficial ownership over such shares except to the extent of his or its pecuniary interest therein, if any. A Form 4 is being filed separately by Mr. Cutler in his capacity as a director of the Issuer. |
| Series D Preferred StockSEC Table II · derivative / convertible security | IndirectDirectly held by General Catalyst Group VIII Supplemental, L.P. | 0 |
Reported balance
After 2020-07-07 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2020-07-07 · Conversion · Disposed 236,931 · Balance 0 F1: Upon the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into shares of the Issuer's common stock on a one-for-one basis. F2: General Catalyst GP VIII, LLC ("GC VIII LLC") is the general partner of General Catalyst Partners VIII, L.P. ("GC VIII LP"), which is the general partner of General Catalyst Group VIII, L.P. ("CG Group VIII") and General Catalyst Group VIII Supplemental, L.P. ("CG Group VIII Supplemental"). General Catalyst Group Management, LLC ("GCGM") is the manager of GC VIII LLC. General Catalyst Group Management Holdings, L.P. ("GCGMH") is the manager of GCGM. F3: General Catalyst Group Management Holdings GP, LLC ("GCGMH LLC") is the general partner of GCGMH. Each of Kenneth Chenault, Joel Cutler, David Fialkow, and Hemant Taneja is a managing director of GCGMH LLC and shares voting and investment power over the shares held by GC Group VIII and GC Group VIII Supplemental. However, each Reporting Person disclaims beneficial ownership over such shares except to the extent of his or its pecuniary interest therein, if any. A Form 4 is being filed separately by Mr. Cutler in his capacity as a director of the Issuer. |
Filing footnotes · ownership attribution and instrument terms
F1: Upon the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into shares of the Issuer's common stock on a one-for-one basis.
F2: General Catalyst GP VIII, LLC ("GC VIII LLC") is the general partner of General Catalyst Partners VIII, L.P. ("GC VIII LP"), which is the general partner of General Catalyst Group VIII, L.P. ("CG Group VIII") and General Catalyst Group VIII Supplemental, L.P. ("CG Group VIII Supplemental"). General Catalyst Group Management, LLC ("GCGM") is the manager of GC VIII LLC. General Catalyst Group Management Holdings, L.P. ("GCGMH") is the manager of GCGM.
F3: General Catalyst Group Management Holdings GP, LLC ("GCGMH LLC") is the general partner of GCGMH. Each of Kenneth Chenault, Joel Cutler, David Fialkow, and Hemant Taneja is a managing director of GCGMH LLC and shares voting and investment power over the shares held by GC Group VIII and GC Group VIII Supplemental. However, each Reporting Person disclaims beneficial ownership over such shares except to the extent of his or its pecuniary interest therein, if any. A Form 4 is being filed separately by Mr. Cutler in his capacity as a director of the Issuer.
Livongo Health, Inc.
Report date October 30, 2020 · Filed November 03, 2020
Section 16 reporting ended · disclosed 2020-11-03. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectSee footnote | 982,160 |
Reported balance
After 2020-10-30 transaction · row 1
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 1 · 2020-10-30 · Other · Acquired 7,922 · Balance 982,160 F1: On October 30, 2020, shares of Common Stock of the Issuer held by 7wire Ventures Fund, L.P. were distributed to its underlying members. As part of such distribution, 7wire Investment Holdings, Ltd., or 7wire, which is wholly owned by General Catalyst Group VIII, L.P., or GC Group VIII LP, received 7,922 shares of the Issuer's Common Stock. |
| Common StockSEC Table I · non-derivative | IndirectSee footnote | 0 |
Reported balance
After 2020-10-30 transaction · row 2
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 2 · 2020-10-30 · Other · Disposed 982,160 · Balance 0 F2: Pursuant to an Agreement and Plan of Merger dated as of August 5, 2020, between Livongo Health, Inc., or Livongo, Teladoc Health, Inc., or Teladoc and Tempranillo Merger Sub, Inc., a wholly owned subsidiary of Teladoc, upon completion of the merger, each share of Livongo common stock was automatically converted into the right to receive 0.5920 of a share of Teladoc common stock and $4.24 in cash, without interest, together with cash in lieu of any fractional shares. F3: 17,933 shares were held by 7wire, and the balance were held by GC Group VIII LP. General Catalyst GP VIII, LLC, or GP VIII LLC, is the general partner of General Catalyst Partners VIII, L.P., or GP VIII LP, which is the general partner of GC Group VIII LP. General Catalyst Group Management, LLC, or GCGM, is the manager of GP VIII LLC. General Catalyst Group Management Holdings, L.P., or GCGMH, is the manager of GCGM. As a Managing Member of General Catalyst Group Management Holdings GP, LLC, or GCGMH LLC, the general partner of GCGMH, the reporting person shared voting and investment power with respect to shares held by 7wire and GC Group VIII LP. |
| Common StockSEC Table I · non-derivative | IndirectSee footnote | 0 |
Reported balance
After 2020-10-30 transaction · row 4
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 4 · 2020-10-30 · Other · Disposed 653,918 · Balance 0 F2: Pursuant to an Agreement and Plan of Merger dated as of August 5, 2020, between Livongo Health, Inc., or Livongo, Teladoc Health, Inc., or Teladoc and Tempranillo Merger Sub, Inc., a wholly owned subsidiary of Teladoc, upon completion of the merger, each share of Livongo common stock was automatically converted into the right to receive 0.5920 of a share of Teladoc common stock and $4.24 in cash, without interest, together with cash in lieu of any fractional shares. F4: The shares were held by GC Venture LH Manager, LLC. GCGMH is the manager of GCGM, which is the manager of GC Venture LH Manager, LLC. GCGM may also be a member of GC Venture LH Manager, LLC with a pecuniary interest in the reported securities. As a Managing Member of GCGMH LLC, the general partner of GCGMH, the reporting person shared voting and investment power with respect to shares held by GC Venture LH Manager, LLC. GCGM Investment Holdings, L.P. is a non-managing member of GC Venture LH Manager, LLC with a pecuniary interest in the reported securities. GC Partners Holdings, L.P. is a limited partner of GCGM Investment Holdings, L.P. with a pecuniary interest in the reported securities. |
| Common StockSEC Table I · non-derivative | IndirectSee footnote | 0 |
Reported balance
After 2020-10-30 transaction · row 5
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 5 · 2020-10-30 · Other · Disposed 2,892,681 · Balance 0 F2: Pursuant to an Agreement and Plan of Merger dated as of August 5, 2020, between Livongo Health, Inc., or Livongo, Teladoc Health, Inc., or Teladoc and Tempranillo Merger Sub, Inc., a wholly owned subsidiary of Teladoc, upon completion of the merger, each share of Livongo common stock was automatically converted into the right to receive 0.5920 of a share of Teladoc common stock and $4.24 in cash, without interest, together with cash in lieu of any fractional shares. F5: The shares were held by General Catalyst Group VIII Supplemental, L.P., or GC Group VIII Supplemental. GP VIII LLC is the general partner of GP VIII LP, which is the general partner of GC Group VIII Supplemental. GCGMH is the manager of GCGM, which is the manager of GP VIII LLC. As a Managing Member of GCGMH LLC, the general partner of GCGMH, the reporting person shared voting and investment power with respect to shares held by GC Group VIII Supplemental. |
| Common StockSEC Table I · non-derivative | IndirectSee footnote | 0 |
Reported balance
After 2020-10-30 transaction · row 6
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 6 · 2020-10-30 · Other · Disposed 13,943,216 · Balance 0 F2: Pursuant to an Agreement and Plan of Merger dated as of August 5, 2020, between Livongo Health, Inc., or Livongo, Teladoc Health, Inc., or Teladoc and Tempranillo Merger Sub, Inc., a wholly owned subsidiary of Teladoc, upon completion of the merger, each share of Livongo common stock was automatically converted into the right to receive 0.5920 of a share of Teladoc common stock and $4.24 in cash, without interest, together with cash in lieu of any fractional shares. F6: The shares were held by GC Group VI LP. General Catalyst GP VI, LLC, or GP VI LLC, is the general partner of General Catalyst Partners VI, L.P., or GP VI LP, which is the general partner of GC Group VI LP. GCGMH is the manager GCGM, which is the manager of GP VI LLC. As a Managing Member of GCGMH LLC, the general partner of GCGMH, the reporting person shared voting and investment power with respect to shares held by GC Group VI LP. GCGM Investment Holdings, L.P. is a limited partner of GC Group VI LP with a pecuniary interest in the reported securities. GC Partners Holdings, L.P. is a limited partner of GCGM Investment Holdings, L.P. with a pecuniary interest in the reported securities. |
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2020-10-30 transaction · row 3
1 source rowRow 3 · 2020-10-30 · Other · Disposed 14,048 · Balance 0 F2: Pursuant to an Agreement and Plan of Merger dated as of August 5, 2020, between Livongo Health, Inc., or Livongo, Teladoc Health, Inc., or Teladoc and Tempranillo Merger Sub, Inc., a wholly owned subsidiary of Teladoc, upon completion of the merger, each share of Livongo common stock was automatically converted into the right to receive 0.5920 of a share of Teladoc common stock and $4.24 in cash, without interest, together with cash in lieu of any fractional shares. |
Filing footnotes · ownership attribution and instrument terms
F1: On October 30, 2020, shares of Common Stock of the Issuer held by 7wire Ventures Fund, L.P. were distributed to its underlying members. As part of such distribution, 7wire Investment Holdings, Ltd., or 7wire, which is wholly owned by General Catalyst Group VIII, L.P., or GC Group VIII LP, received 7,922 shares of the Issuer's Common Stock.
F2: Pursuant to an Agreement and Plan of Merger dated as of August 5, 2020, between Livongo Health, Inc., or Livongo, Teladoc Health, Inc., or Teladoc and Tempranillo Merger Sub, Inc., a wholly owned subsidiary of Teladoc, upon completion of the merger, each share of Livongo common stock was automatically converted into the right to receive 0.5920 of a share of Teladoc common stock and $4.24 in cash, without interest, together with cash in lieu of any fractional shares.
F3: 17,933 shares were held by 7wire, and the balance were held by GC Group VIII LP. General Catalyst GP VIII, LLC, or GP VIII LLC, is the general partner of General Catalyst Partners VIII, L.P., or GP VIII LP, which is the general partner of GC Group VIII LP. General Catalyst Group Management, LLC, or GCGM, is the manager of GP VIII LLC. General Catalyst Group Management Holdings, L.P., or GCGMH, is the manager of GCGM. As a Managing Member of General Catalyst Group Management Holdings GP, LLC, or GCGMH LLC, the general partner of GCGMH, the reporting person shared voting and investment power with respect to shares held by 7wire and GC Group VIII LP.
F4: The shares were held by GC Venture LH Manager, LLC. GCGMH is the manager of GCGM, which is the manager of GC Venture LH Manager, LLC. GCGM may also be a member of GC Venture LH Manager, LLC with a pecuniary interest in the reported securities. As a Managing Member of GCGMH LLC, the general partner of GCGMH, the reporting person shared voting and investment power with respect to shares held by GC Venture LH Manager, LLC. GCGM Investment Holdings, L.P. is a non-managing member of GC Venture LH Manager, LLC with a pecuniary interest in the reported securities. GC Partners Holdings, L.P. is a limited partner of GCGM Investment Holdings, L.P. with a pecuniary interest in the reported securities.
F5: The shares were held by General Catalyst Group VIII Supplemental, L.P., or GC Group VIII Supplemental. GP VIII LLC is the general partner of GP VIII LP, which is the general partner of GC Group VIII Supplemental. GCGMH is the manager of GCGM, which is the manager of GP VIII LLC. As a Managing Member of GCGMH LLC, the general partner of GCGMH, the reporting person shared voting and investment power with respect to shares held by GC Group VIII Supplemental.
F6: The shares were held by GC Group VI LP. General Catalyst GP VI, LLC, or GP VI LLC, is the general partner of General Catalyst Partners VI, L.P., or GP VI LP, which is the general partner of GC Group VI LP. GCGMH is the manager GCGM, which is the manager of GP VI LLC. As a Managing Member of GCGMH LLC, the general partner of GCGMH, the reporting person shared voting and investment power with respect to shares held by GC Group VI LP. GCGM Investment Holdings, L.P. is a limited partner of GC Group VI LP with a pecuniary interest in the reported securities. GC Partners Holdings, L.P. is a limited partner of GCGM Investment Holdings, L.P. with a pecuniary interest in the reported securities.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 16, 2021 Filed Mar 19, 2021 00:11 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | OtherCommon Stock | 214,302 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-21-002839 · form4.xml · nonDerivative · entry 1 Taneja Hemant · CIK 0001545563 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 0 F1 · kind: Effective March 16, 2021, General Catalyst Partners VI L.P., or GP VI LP, distributed these shares to its limited partners on a pro rata basis, in-kind, without consideration. F1 · ownership.nature: Effective March 16, 2021, General Catalyst Partners VI L.P., or GP VI LP, distributed these shares to its limited partners on a pro rata basis, in-kind, without consideration. Read SEC document |
| March 12, 2021 Filed Mar 15, 2021 22:33 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | OtherCommon Stock | 44,996 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-21-002725 · form4.xml · nonDerivative · entry 7 Taneja Hemant · CIK 0001545563 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 44,996 F10 · kind: Shares acquired through a distribution in-kind from GC Group VIII Supplemental by GP VIII LP. GP VIII LLC is the general partner of GP VIII LP, which is the general partner of GC Group VIII Supplemental. GCGMH is the manager of GCGM, which is the manager of GP VIII LLC. As a Managing Member of GCGMH LLC, the general partner of GCGMH, the reporting person shares voting and investment power with respect to shares held by GC Group VIII Supplemental. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest in such securities. F10 · ownership.nature: Shares acquired through a distribution in-kind from GC Group VIII Supplemental by GP VIII LP. GP VIII LLC is the general partner of GP VIII LP, which is the general partner of GC Group VIII Supplemental. GCGMH is the manager of GCGM, which is the manager of GP VIII LLC. As a Managing Member of GCGMH LLC, the general partner of GCGMH, the reporting person shares voting and investment power with respect to shares held by GC Group VIII Supplemental. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest in such securities. Read SEC document |
| March 12, 2021 Filed Mar 15, 2021 22:33 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | OtherCommon Stock | 218,124 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-21-002725 · form4.xml · nonDerivative · entry 6 Taneja Hemant · CIK 0001545563 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 1,090,622 F8 · kind: Effective March 12, 2021, General Catalyst Group VIII Supplemental, L.P., or GC Group VIII Supplemental, a venture capital partnership, distributed these shares to its partners on a pro rata basis, in-kind, without consideration. F9 · ownership.nature: The remaining securities are held by General Catalyst Group VIII Supplemental, L.P., or GC Group VIII Supplemental. GP VIII LLC is the general partner of GP VIII LP, which is the general partner of GC Group VIII Supplemental. GCGMH is the manager of GCGM, which is the manager of GP VIII LLC. As a Managing Member of GCGMH LLC, the general partner of GCGMH, the reporting person shares voting and investment power with respect to shares held by GC Group VIII Supplemental. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest in such securities. Read SEC document |
| March 12, 2021 Filed Mar 15, 2021 22:33 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | OtherCommon Stock | 214,302 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-21-002725 · form4.xml · nonDerivative · entry 5 Taneja Hemant · CIK 0001545563 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 214,302 F7 · kind: Shares acquired through a distribution in-kind from GC Group VI LP by General Catalyst Partners VI, L.P., or GP VI LP. General Catalyst GP VI, LLC, or GP VI LLC, is the general partner of GP VI LP, which is the general partner of GC Group VI LP. GCGMH is the manager GCGM, which is the manager of GP VI LLC. As a Managing Member of GCGMH LLC, the general partner of GCGMH, the reporting person shares voting and investment power with respect to shares held by GP VI LP. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest in such securities. F7 · ownership.nature: Shares acquired through a distribution in-kind from GC Group VI LP by General Catalyst Partners VI, L.P., or GP VI LP. General Catalyst GP VI, LLC, or GP VI LLC, is the general partner of GP VI LP, which is the general partner of GC Group VI LP. GCGMH is the manager GCGM, which is the manager of GP VI LLC. As a Managing Member of GCGMH LLC, the general partner of GCGMH, the reporting person shares voting and investment power with respect to shares held by GP VI LP. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest in such securities. Read SEC document |
| March 12, 2021 Filed Mar 15, 2021 22:33 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | OtherCommon Stock | 1,051,396 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-21-002725 · form4.xml · nonDerivative · entry 4 Taneja Hemant · CIK 0001545563 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 5,256,977 F5 · kind: Effective March 12, 2021, General Catalyst Group VI, L.P., or GC Group VI LP, a venture capital partnership, distributed these shares to its partners on a pro rata basis, in-kind, without consideration. F6 · ownership.nature: The remaining securities are held by GC Group VI LP. General Catalyst GP VI, LLC, or GP VI LLC, is the general partner of General Catalyst Partners VI, L.P., or GP VI LP, which is the general partner of GC Group VI LP. GCGMH is the manager GCGM, which is the manager of GP VI LLC. As a Managing Member of GCGMH LLC, the general partner of GCGMH, the reporting person shares voting and investment power with respect to shares held by GC Group VI LP. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest in such securities. Read SEC document |
| March 11, 2021 Filed Mar 15, 2021 22:33 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 620 | $199.81 | $123,882.76 |
DisclosureSEC source: 0001062993-21-002725 · form4.xml · nonDerivative · entry 3 Taneja Hemant · CIK 0001545563 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 373,361 F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $199.77 to $199.88, inclusive. F2 · ownership.nature: 10,616 shares are held by 7wire Investment Holdings, Ltd., or 7wire, which is wholly owned by General Catalyst Group VIII, L.P., or GC Group VIII LP, and the balance are held by GC Group VIII LP. General Catalyst GP VIII, LLC, or GP VIII LLC, is the general partner of General Catalyst Partners VIII, L.P., or GP VIII LP, which is the general partner of GC Group VIII LP. General Catalyst Group Management, LLC, or GCGM, is the manager of GP VIII LLC. General Catalyst Group Management Holdings, L.P., or GCGMH, is the manager of GCGM. As a Managing Member of GCGMH LLC, the general partner of GCGMH, the reporting person shares voting and investment power with respect to shares held by 7wire and GC Group VIII LP. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest in such securities. Read SEC document |
| March 11, 2021 Filed Mar 15, 2021 22:33 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 6,232 | $198.91 | $1,239,630.18 |
DisclosureSEC source: 0001062993-21-002725 · form4.xml · nonDerivative · entry 2 Taneja Hemant · CIK 0001545563 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 373,981 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $198.70 to $199.54, inclusive. F2 · ownership.nature: 10,616 shares are held by 7wire Investment Holdings, Ltd., or 7wire, which is wholly owned by General Catalyst Group VIII, L.P., or GC Group VIII LP, and the balance are held by GC Group VIII LP. General Catalyst GP VIII, LLC, or GP VIII LLC, is the general partner of General Catalyst Partners VIII, L.P., or GP VIII LP, which is the general partner of GC Group VIII LP. General Catalyst Group Management, LLC, or GCGM, is the manager of GP VIII LLC. General Catalyst Group Management Holdings, L.P., or GCGMH, is the manager of GCGM. As a Managing Member of GCGMH LLC, the general partner of GCGMH, the reporting person shares voting and investment power with respect to shares held by 7wire and GC Group VIII LP. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest in such securities. Read SEC document |
| March 11, 2021 Filed Mar 15, 2021 22:33 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 65,697 | $198.23 | $13,023,182.01 |
DisclosureSEC source: 0001062993-21-002725 · form4.xml · nonDerivative · entry 1 Taneja Hemant · CIK 0001545563 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 380,213 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $197.69 to $198.67, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. F2 · ownership.nature: 10,616 shares are held by 7wire Investment Holdings, Ltd., or 7wire, which is wholly owned by General Catalyst Group VIII, L.P., or GC Group VIII LP, and the balance are held by GC Group VIII LP. General Catalyst GP VIII, LLC, or GP VIII LLC, is the general partner of General Catalyst Partners VIII, L.P., or GP VIII LP, which is the general partner of GC Group VIII LP. General Catalyst Group Management, LLC, or GCGM, is the manager of GP VIII LLC. General Catalyst Group Management Holdings, L.P., or GCGMH, is the manager of GCGM. As a Managing Member of GCGMH LLC, the general partner of GCGMH, the reporting person shares voting and investment power with respect to shares held by 7wire and GC Group VIII LP. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest in such securities. Read SEC document |
| December 08, 2020 Filed Dec 10, 2020 21:37 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 4,900 | $197.39 | $967,206.59 |
DisclosureSEC source: 0001062993-20-006225 · form4.xml · nonDerivative · entry 1 Taneja Hemant · CIK 0001545563 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 0 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $197.13 to $197.68, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. F2 · ownership.nature: The shares were held by GCGM Investment Holdings, L.P., or GCGM IH. As a Managing Member of General Catalyst Group Management Holdings GP, LLC, or GCGMH LLC, the general partner of GCGM IH, the reporting person shared voting and investment power with respect to shares held by GCGM IH. Read SEC document |
| October 30, 2020 Filed Nov 3, 2020 22:03 UTC | Livongo Health, Inc. LVGO · Entity 145566 | OtherCommon Stock | 13,943,216 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001012975-20-000802 · edgar.xml · nonDerivative · entry 6 Taneja Hemant · CIK 0001545563 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 0 F2 · price: Pursuant to an Agreement and Plan of Merger dated as of August 5, 2020, between Livongo Health, Inc., or Livongo, Teladoc Health, Inc., or Teladoc and Tempranillo Merger Sub, Inc., a wholly owned subsidiary of Teladoc, upon completion of the merger, each share of Livongo common stock was automatically converted into the right to receive 0.5920 of a share of Teladoc common stock and $4.24 in cash, without interest, together with cash in lieu of any fractional shares. F6 · ownership.nature: The shares were held by GC Group VI LP. General Catalyst GP VI, LLC, or GP VI LLC, is the general partner of General Catalyst Partners VI, L.P., or GP VI LP, which is the general partner of GC Group VI LP. GCGMH is the manager GCGM, which is the manager of GP VI LLC. As a Managing Member of GCGMH LLC, the general partner of GCGMH, the reporting person shared voting and investment power with respect to shares held by GC Group VI LP. GCGM Investment Holdings, L.P. is a limited partner of GC Group VI LP with a pecuniary interest in the reported securities. GC Partners Holdings, L.P. is a limited partner of GCGM Investment Holdings, L.P. with a pecuniary interest in the reported securities. Read SEC document |
| October 30, 2020 Filed Nov 3, 2020 22:03 UTC | Livongo Health, Inc. LVGO · Entity 145566 | OtherCommon Stock | 2,892,681 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001012975-20-000802 · edgar.xml · nonDerivative · entry 5 Taneja Hemant · CIK 0001545563 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 0 F2 · price: Pursuant to an Agreement and Plan of Merger dated as of August 5, 2020, between Livongo Health, Inc., or Livongo, Teladoc Health, Inc., or Teladoc and Tempranillo Merger Sub, Inc., a wholly owned subsidiary of Teladoc, upon completion of the merger, each share of Livongo common stock was automatically converted into the right to receive 0.5920 of a share of Teladoc common stock and $4.24 in cash, without interest, together with cash in lieu of any fractional shares. F5 · ownership.nature: The shares were held by General Catalyst Group VIII Supplemental, L.P., or GC Group VIII Supplemental. GP VIII LLC is the general partner of GP VIII LP, which is the general partner of GC Group VIII Supplemental. GCGMH is the manager of GCGM, which is the manager of GP VIII LLC. As a Managing Member of GCGMH LLC, the general partner of GCGMH, the reporting person shared voting and investment power with respect to shares held by GC Group VIII Supplemental. Read SEC document |
| October 30, 2020 Filed Nov 3, 2020 22:03 UTC | Livongo Health, Inc. LVGO · Entity 145566 | OtherCommon Stock | 653,918 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001012975-20-000802 · edgar.xml · nonDerivative · entry 4 Taneja Hemant · CIK 0001545563 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 0 F2 · price: Pursuant to an Agreement and Plan of Merger dated as of August 5, 2020, between Livongo Health, Inc., or Livongo, Teladoc Health, Inc., or Teladoc and Tempranillo Merger Sub, Inc., a wholly owned subsidiary of Teladoc, upon completion of the merger, each share of Livongo common stock was automatically converted into the right to receive 0.5920 of a share of Teladoc common stock and $4.24 in cash, without interest, together with cash in lieu of any fractional shares. F4 · ownership.nature: The shares were held by GC Venture LH Manager, LLC. GCGMH is the manager of GCGM, which is the manager of GC Venture LH Manager, LLC. GCGM may also be a member of GC Venture LH Manager, LLC with a pecuniary interest in the reported securities. As a Managing Member of GCGMH LLC, the general partner of GCGMH, the reporting person shared voting and investment power with respect to shares held by GC Venture LH Manager, LLC. GCGM Investment Holdings, L.P. is a non-managing member of GC Venture LH Manager, LLC with a pecuniary interest in the reported securities. GC Partners Holdings, L.P. is a limited partner of GCGM Investment Holdings, L.P. with a pecuniary interest in the reported securities. Read SEC document |
| October 30, 2020 Filed Nov 3, 2020 22:03 UTC | Livongo Health, Inc. LVGO · Entity 145566 | OtherCommon Stock | 14,048 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001012975-20-000802 · edgar.xml · nonDerivative · entry 3 Taneja Hemant · CIK 0001545563 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F2 · price: Pursuant to an Agreement and Plan of Merger dated as of August 5, 2020, between Livongo Health, Inc., or Livongo, Teladoc Health, Inc., or Teladoc and Tempranillo Merger Sub, Inc., a wholly owned subsidiary of Teladoc, upon completion of the merger, each share of Livongo common stock was automatically converted into the right to receive 0.5920 of a share of Teladoc common stock and $4.24 in cash, without interest, together with cash in lieu of any fractional shares. Read SEC document |
| October 30, 2020 Filed Nov 3, 2020 22:03 UTC | Livongo Health, Inc. LVGO · Entity 145566 | OtherCommon Stock | 982,160 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001012975-20-000802 · edgar.xml · nonDerivative · entry 2 Taneja Hemant · CIK 0001545563 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 0 F2 · price: Pursuant to an Agreement and Plan of Merger dated as of August 5, 2020, between Livongo Health, Inc., or Livongo, Teladoc Health, Inc., or Teladoc and Tempranillo Merger Sub, Inc., a wholly owned subsidiary of Teladoc, upon completion of the merger, each share of Livongo common stock was automatically converted into the right to receive 0.5920 of a share of Teladoc common stock and $4.24 in cash, without interest, together with cash in lieu of any fractional shares. F3 · ownership.nature: 17,933 shares were held by 7wire, and the balance were held by GC Group VIII LP. General Catalyst GP VIII, LLC, or GP VIII LLC, is the general partner of General Catalyst Partners VIII, L.P., or GP VIII LP, which is the general partner of GC Group VIII LP. General Catalyst Group Management, LLC, or GCGM, is the manager of GP VIII LLC. General Catalyst Group Management Holdings, L.P., or GCGMH, is the manager of GCGM. As a Managing Member of General Catalyst Group Management Holdings GP, LLC, or GCGMH LLC, the general partner of GCGMH, the reporting person shared voting and investment power with respect to shares held by 7wire and GC Group VIII LP. Read SEC document |
| October 30, 2020 Filed Nov 3, 2020 22:03 UTC | Livongo Health, Inc. LVGO · Entity 145566 | OtherCommon Stock | 7,922 | $0.00 | $0.00 |
DisclosureSEC source: 0001012975-20-000802 · edgar.xml · nonDerivative · entry 1 Taneja Hemant · CIK 0001545563 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 982,160 F1 · ownership.nature: On October 30, 2020, shares of Common Stock of the Issuer held by 7wire Ventures Fund, L.P. were distributed to its underlying members. As part of such distribution, 7wire Investment Holdings, Ltd., or 7wire, which is wholly owned by General Catalyst Group VIII, L.P., or GC Group VIII LP, received 7,922 shares of the Issuer's Common Stock. Read SEC document |
| September 10, 2020 Filed Sep 14, 2020 23:10 UTC | Livongo Health, Inc. LVGO · Entity 145566 | OtherCommon Stock | 3,174 | $0.00 | $0.00 |
DisclosureSEC source: 0001012975-20-000723 · edgar.xml · nonDerivative · entry 1 Taneja Hemant · CIK 0001545563 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 974,238 F1 · kind: On September 10, 2020, shares of Common Stock of the Issuer held by 7wire Ventures Fund, L.P. were distributed to its underlying members. As part of such distribution, 7wire Investment Holdings, Ltd., or 7wire, which is wholly owned by General Catalyst Group VIII, L.P., or GC Group VIII LP, received 3,174 shares of the Issuer's Common Stock. F2 · ownership.nature: 10,011 shares are held by 7wire and the balance are held by GC Group VIII LP. General Catalyst GP VIII, LLC, or GP VIII LLC, is the general partner of General Catalyst Partners VIII, L.P., or GP VIII LP, which is the general partner of GC Group VIII LP. General Catalyst Group Management, LLC, or GCGM, is the manager of GP VIII LLC. General Catalyst Group Management Holdings, L.P., or GCGMH, is the manager of GCGM. As a Managing Member of General Catalyst Group Management Holdings GP, LLC, or GCGMH LLC, the general partner of GCGMH, the reporting person shares voting and investment power with respect to shares held by 7wire and GC Group VIII LP. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest in such securities. Read SEC document |
| July 29, 2020 Filed Jul 31, 2020 23:39 UTC | Livongo Health, Inc. LVGO · Entity 145566 | OtherCommon Stock | 653,918 | $0.00 | $0.00 |
DisclosureSEC source: 0001012975-20-000671 · edgar.xml · nonDerivative · entry 2 Taneja Hemant · CIK 0001545563 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 653,918 F3 · kind: As part of the distribution described in footnote 1, GC Venture LH Manager, LLC received 653,918 shares of the Issuer's Common Stock. F4 · ownership.nature: The shares are held by GC Venture LH Manager, LLC. GCGMH is the manager of GCGM, which is the manager of GC Venture LH Manager, LLC. GCGM may also be a member of GC Venture LH Manager, LLC with a pecuniary interest in the reported securities. As a Managing Member of GCGMH LLC, the general partner of GCGMH, the reporting person shares voting and investment power with respect to shares held by GC Venture LH Manager, LLC. GCGM Investment Holdings, L.P. is a non-managing member of GC Venture LH Manager, LLC with a pecuniary interest in the reported securities. GC Partners Holdings, L.P. is a limited partner of GCGM Investment Holdings, L.P. with a pecuniary interest in the reported securities. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest in such securities. Read SEC document |
| July 29, 2020 Filed Jul 31, 2020 23:39 UTC | Livongo Health, Inc. LVGO · Entity 145566 | OtherCommon Stock | 2,678,571 | $0.00 | $0.00 |
DisclosureSEC source: 0001012975-20-000671 · edgar.xml · nonDerivative · entry 1 Taneja Hemant · CIK 0001545563 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 0 F1 · kind: GC Venture LH, LLC distributed these shares to its members on a pro rata basis for no consideration and no longer holds any shares. F2 · ownership.nature: General Catalyst Group Management Holdings, L.P., or GCGMH, is the manager of General Catalyst Group Management, LLC, or GCGM, which is the manager of GC Venture LH Manager, LLC, which is the manager and a member of GC Venture LH, LLC. GCGM may also be a member of GC Venture LH Manager, LLC with a pecuniary interest in the reported securities. As a Managing Member of General Catalyst Group Management Holdings GP, LLC, or GCGMH LLC, the general partner of GCGMH, the reporting person shares voting and investment power with respect to shares held by GC Venture LH, LLC. GCGM Investment Holdings, L.P. is a non-managing member of GC Venture LH Manager, LLC with a pecuniary interest in the reported securities. GC Partners Holdings, L.P. is a limited partner of GCGM Investment Holdings, L.P. with a pecuniary interest in the reported securities. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest in such securities. Read SEC document |
| July 07, 2020 Filed Jul 8, 2020 20:02 UTC | Lemonade, Inc. LMND · Entity 4057 | ConversionSeries D Preferred Stock · Derivative | 236,931 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-20-082065 · a4.xml · derivative · entry 7 General Catalyst Group Management Holdings GP, LLC · CIK 0001774565 · 10% owner General Catalyst Group Management Holdings, L.P. · CIK 0001774564 · 10% owner General Catalyst Group Management, LLC · CIK 0001637946 · 10% owner General Catalyst GP VIII, LLC · CIK 0001758432 · 10% owner General Catalyst Partners VIII, L.P. · CIK 0001758429 · 10% owner General Catalyst Group VIII, L.P. · CIK 0001663852 · 10% owner General Catalyst Group VIII Supplemental, L.P. · CIK 0001663855 · 10% owner CHENAULT KENNETH I · CIK 0001180524 · 10% owner Taneja Hemant · CIK 0001545563 · 10% owner Fialkow David P · CIK 0001337220 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Directly held by General Catalyst Group VIII Supplemental, L.P. Disclosed balance after: 0 Underlying: Common Stock · 236,931 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Upon the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into shares of the Issuer's common stock on a one-for-one basis. F1 · price: Upon the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into shares of the Issuer's common stock on a one-for-one basis. F1 · derivative.exercise_date: Upon the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into shares of the Issuer's common stock on a one-for-one basis. F1 · derivative.expiration_date: Upon the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into shares of the Issuer's common stock on a one-for-one basis. F2 · ownership.nature: General Catalyst GP VIII, LLC ("GC VIII LLC") is the general partner of General Catalyst Partners VIII, L.P. ("GC VIII LP"), which is the general partner of General Catalyst Group VIII, L.P. ("CG Group VIII") and General Catalyst Group VIII Supplemental, L.P. ("CG Group VIII Supplemental"). General Catalyst Group Management, LLC ("GCGM") is the manager of GC VIII LLC. General Catalyst Group Management Holdings, L.P. ("GCGMH") is the manager of GCGM. F3 · ownership.nature: General Catalyst Group Management Holdings GP, LLC ("GCGMH LLC") is the general partner of GCGMH. Each of Kenneth Chenault, Joel Cutler, David Fialkow, and Hemant Taneja is a managing director of GCGMH LLC and shares voting and investment power over the shares held by GC Group VIII and GC Group VIII Supplemental. However, each Reporting Person disclaims beneficial ownership over such shares except to the extent of his or its pecuniary interest therein, if any. A Form 4 is being filed separately by Mr. Cutler in his capacity as a director of the Issuer. Read SEC document |
| July 07, 2020 Filed Jul 8, 2020 20:02 UTC | Lemonade, Inc. LMND · Entity 4057 | ConversionSeries C Preferred Stock · Derivative | 335,070 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-20-082065 · a4.xml · derivative · entry 6 General Catalyst Group Management Holdings GP, LLC · CIK 0001774565 · 10% owner General Catalyst Group Management Holdings, L.P. · CIK 0001774564 · 10% owner General Catalyst Group Management, LLC · CIK 0001637946 · 10% owner General Catalyst GP VIII, LLC · CIK 0001758432 · 10% owner General Catalyst Partners VIII, L.P. · CIK 0001758429 · 10% owner General Catalyst Group VIII, L.P. · CIK 0001663852 · 10% owner General Catalyst Group VIII Supplemental, L.P. · CIK 0001663855 · 10% owner CHENAULT KENNETH I · CIK 0001180524 · 10% owner Taneja Hemant · CIK 0001545563 · 10% owner Fialkow David P · CIK 0001337220 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Directly held by General Catalyst Group VIII Supplemental, L.P. Disclosed balance after: 0 Underlying: Common Stock · 335,070 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Upon the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into shares of the Issuer's common stock on a one-for-one basis. F1 · price: Upon the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into shares of the Issuer's common stock on a one-for-one basis. F1 · derivative.exercise_date: Upon the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into shares of the Issuer's common stock on a one-for-one basis. F1 · derivative.expiration_date: Upon the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into shares of the Issuer's common stock on a one-for-one basis. F2 · ownership.nature: General Catalyst GP VIII, LLC ("GC VIII LLC") is the general partner of General Catalyst Partners VIII, L.P. ("GC VIII LP"), which is the general partner of General Catalyst Group VIII, L.P. ("CG Group VIII") and General Catalyst Group VIII Supplemental, L.P. ("CG Group VIII Supplemental"). General Catalyst Group Management, LLC ("GCGM") is the manager of GC VIII LLC. General Catalyst Group Management Holdings, L.P. ("GCGMH") is the manager of GCGM. F3 · ownership.nature: General Catalyst Group Management Holdings GP, LLC ("GCGMH LLC") is the general partner of GCGMH. Each of Kenneth Chenault, Joel Cutler, David Fialkow, and Hemant Taneja is a managing director of GCGMH LLC and shares voting and investment power over the shares held by GC Group VIII and GC Group VIII Supplemental. However, each Reporting Person disclaims beneficial ownership over such shares except to the extent of his or its pecuniary interest therein, if any. A Form 4 is being filed separately by Mr. Cutler in his capacity as a director of the Issuer. Read SEC document |
| July 07, 2020 Filed Jul 8, 2020 20:02 UTC | Lemonade, Inc. LMND · Entity 4057 | ConversionSeries C Preferred Stock · Derivative | 335,070 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-20-082065 · a4.xml · derivative · entry 5 General Catalyst Group Management Holdings GP, LLC · CIK 0001774565 · 10% owner General Catalyst Group Management Holdings, L.P. · CIK 0001774564 · 10% owner General Catalyst Group Management, LLC · CIK 0001637946 · 10% owner General Catalyst GP VIII, LLC · CIK 0001758432 · 10% owner General Catalyst Partners VIII, L.P. · CIK 0001758429 · 10% owner General Catalyst Group VIII, L.P. · CIK 0001663852 · 10% owner General Catalyst Group VIII Supplemental, L.P. · CIK 0001663855 · 10% owner CHENAULT KENNETH I · CIK 0001180524 · 10% owner Taneja Hemant · CIK 0001545563 · 10% owner Fialkow David P · CIK 0001337220 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Directly held by General Catalyst Group VIII, L.P. Disclosed balance after: 0 Underlying: Common Stock · 335,070 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Upon the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into shares of the Issuer's common stock on a one-for-one basis. F1 · price: Upon the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into shares of the Issuer's common stock on a one-for-one basis. F1 · derivative.exercise_date: Upon the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into shares of the Issuer's common stock on a one-for-one basis. F1 · derivative.expiration_date: Upon the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into shares of the Issuer's common stock on a one-for-one basis. F2 · ownership.nature: General Catalyst GP VIII, LLC ("GC VIII LLC") is the general partner of General Catalyst Partners VIII, L.P. ("GC VIII LP"), which is the general partner of General Catalyst Group VIII, L.P. ("CG Group VIII") and General Catalyst Group VIII Supplemental, L.P. ("CG Group VIII Supplemental"). General Catalyst Group Management, LLC ("GCGM") is the manager of GC VIII LLC. General Catalyst Group Management Holdings, L.P. ("GCGMH") is the manager of GCGM. F3 · ownership.nature: General Catalyst Group Management Holdings GP, LLC ("GCGMH LLC") is the general partner of GCGMH. Each of Kenneth Chenault, Joel Cutler, David Fialkow, and Hemant Taneja is a managing director of GCGMH LLC and shares voting and investment power over the shares held by GC Group VIII and GC Group VIII Supplemental. However, each Reporting Person disclaims beneficial ownership over such shares except to the extent of his or its pecuniary interest therein, if any. A Form 4 is being filed separately by Mr. Cutler in his capacity as a director of the Issuer. Read SEC document |
| July 07, 2020 Filed Jul 8, 2020 20:02 UTC | Lemonade, Inc. LMND · Entity 4057 | ConversionSeries B Preferred Stock · Derivative | 1,157,621 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-20-082065 · a4.xml · derivative · entry 4 General Catalyst Group Management Holdings GP, LLC · CIK 0001774565 · 10% owner General Catalyst Group Management Holdings, L.P. · CIK 0001774564 · 10% owner General Catalyst Group Management, LLC · CIK 0001637946 · 10% owner General Catalyst GP VIII, LLC · CIK 0001758432 · 10% owner General Catalyst Partners VIII, L.P. · CIK 0001758429 · 10% owner General Catalyst Group VIII, L.P. · CIK 0001663852 · 10% owner General Catalyst Group VIII Supplemental, L.P. · CIK 0001663855 · 10% owner CHENAULT KENNETH I · CIK 0001180524 · 10% owner Taneja Hemant · CIK 0001545563 · 10% owner Fialkow David P · CIK 0001337220 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Directly held by General Catalyst Group VIII Supplemental, L.P. Disclosed balance after: 0 Underlying: Common Stock · 1,157,621 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Upon the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into shares of the Issuer's common stock on a one-for-one basis. F1 · price: Upon the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into shares of the Issuer's common stock on a one-for-one basis. F1 · derivative.exercise_date: Upon the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into shares of the Issuer's common stock on a one-for-one basis. F1 · derivative.expiration_date: Upon the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into shares of the Issuer's common stock on a one-for-one basis. F2 · ownership.nature: General Catalyst GP VIII, LLC ("GC VIII LLC") is the general partner of General Catalyst Partners VIII, L.P. ("GC VIII LP"), which is the general partner of General Catalyst Group VIII, L.P. ("CG Group VIII") and General Catalyst Group VIII Supplemental, L.P. ("CG Group VIII Supplemental"). General Catalyst Group Management, LLC ("GCGM") is the manager of GC VIII LLC. General Catalyst Group Management Holdings, L.P. ("GCGMH") is the manager of GCGM. F3 · ownership.nature: General Catalyst Group Management Holdings GP, LLC ("GCGMH LLC") is the general partner of GCGMH. Each of Kenneth Chenault, Joel Cutler, David Fialkow, and Hemant Taneja is a managing director of GCGMH LLC and shares voting and investment power over the shares held by GC Group VIII and GC Group VIII Supplemental. However, each Reporting Person disclaims beneficial ownership over such shares except to the extent of his or its pecuniary interest therein, if any. A Form 4 is being filed separately by Mr. Cutler in his capacity as a director of the Issuer. Read SEC document |
| July 07, 2020 Filed Jul 8, 2020 20:02 UTC | Lemonade, Inc. LMND · Entity 4057 | ConversionSeries B Preferred Stock · Derivative | 1,157,621 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-20-082065 · a4.xml · derivative · entry 3 General Catalyst Group Management Holdings GP, LLC · CIK 0001774565 · 10% owner General Catalyst Group Management Holdings, L.P. · CIK 0001774564 · 10% owner General Catalyst Group Management, LLC · CIK 0001637946 · 10% owner General Catalyst GP VIII, LLC · CIK 0001758432 · 10% owner General Catalyst Partners VIII, L.P. · CIK 0001758429 · 10% owner General Catalyst Group VIII, L.P. · CIK 0001663852 · 10% owner General Catalyst Group VIII Supplemental, L.P. · CIK 0001663855 · 10% owner CHENAULT KENNETH I · CIK 0001180524 · 10% owner Taneja Hemant · CIK 0001545563 · 10% owner Fialkow David P · CIK 0001337220 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Directly held by General Catalyst Group VIII, L.P. Disclosed balance after: 0 Underlying: Common Stock · 1,157,621 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Upon the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into shares of the Issuer's common stock on a one-for-one basis. F1 · price: Upon the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into shares of the Issuer's common stock on a one-for-one basis. F1 · derivative.exercise_date: Upon the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into shares of the Issuer's common stock on a one-for-one basis. F1 · derivative.expiration_date: Upon the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into shares of the Issuer's common stock on a one-for-one basis. F2 · ownership.nature: General Catalyst GP VIII, LLC ("GC VIII LLC") is the general partner of General Catalyst Partners VIII, L.P. ("GC VIII LP"), which is the general partner of General Catalyst Group VIII, L.P. ("CG Group VIII") and General Catalyst Group VIII Supplemental, L.P. ("CG Group VIII Supplemental"). General Catalyst Group Management, LLC ("GCGM") is the manager of GC VIII LLC. General Catalyst Group Management Holdings, L.P. ("GCGMH") is the manager of GCGM. F3 · ownership.nature: General Catalyst Group Management Holdings GP, LLC ("GCGMH LLC") is the general partner of GCGMH. Each of Kenneth Chenault, Joel Cutler, David Fialkow, and Hemant Taneja is a managing director of GCGMH LLC and shares voting and investment power over the shares held by GC Group VIII and GC Group VIII Supplemental. However, each Reporting Person disclaims beneficial ownership over such shares except to the extent of his or its pecuniary interest therein, if any. A Form 4 is being filed separately by Mr. Cutler in his capacity as a director of the Issuer. Read SEC document |
| July 07, 2020 Filed Jul 8, 2020 20:02 UTC | Lemonade, Inc. LMND · Entity 4057 | ConversionCommon Stock | 1,729,622 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-20-082065 · a4.xml · nonDerivative · entry 2 General Catalyst Group Management Holdings GP, LLC · CIK 0001774565 · 10% owner General Catalyst Group Management Holdings, L.P. · CIK 0001774564 · 10% owner General Catalyst Group Management, LLC · CIK 0001637946 · 10% owner General Catalyst GP VIII, LLC · CIK 0001758432 · 10% owner General Catalyst Partners VIII, L.P. · CIK 0001758429 · 10% owner General Catalyst Group VIII, L.P. · CIK 0001663852 · 10% owner General Catalyst Group VIII Supplemental, L.P. · CIK 0001663855 · 10% owner CHENAULT KENNETH I · CIK 0001180524 · 10% owner Taneja Hemant · CIK 0001545563 · 10% owner Fialkow David P · CIK 0001337220 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Directly held by General Catalyst Group VIII Supplemental, L.P. Disclosed balance after: 1,729,622 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Upon the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into shares of the Issuer's common stock on a one-for-one basis. F1 · price: Upon the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into shares of the Issuer's common stock on a one-for-one basis. F2 · ownership.nature: General Catalyst GP VIII, LLC ("GC VIII LLC") is the general partner of General Catalyst Partners VIII, L.P. ("GC VIII LP"), which is the general partner of General Catalyst Group VIII, L.P. ("CG Group VIII") and General Catalyst Group VIII Supplemental, L.P. ("CG Group VIII Supplemental"). General Catalyst Group Management, LLC ("GCGM") is the manager of GC VIII LLC. General Catalyst Group Management Holdings, L.P. ("GCGMH") is the manager of GCGM. F3 · ownership.nature: General Catalyst Group Management Holdings GP, LLC ("GCGMH LLC") is the general partner of GCGMH. Each of Kenneth Chenault, Joel Cutler, David Fialkow, and Hemant Taneja is a managing director of GCGMH LLC and shares voting and investment power over the shares held by GC Group VIII and GC Group VIII Supplemental. However, each Reporting Person disclaims beneficial ownership over such shares except to the extent of his or its pecuniary interest therein, if any. A Form 4 is being filed separately by Mr. Cutler in his capacity as a director of the Issuer. Read SEC document |
| July 07, 2020 Filed Jul 8, 2020 20:02 UTC | Lemonade, Inc. LMND · Entity 4057 | ConversionCommon Stock | 1,492,691 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-20-082065 · a4.xml · nonDerivative · entry 1 General Catalyst Group Management Holdings GP, LLC · CIK 0001774565 · 10% owner General Catalyst Group Management Holdings, L.P. · CIK 0001774564 · 10% owner General Catalyst Group Management, LLC · CIK 0001637946 · 10% owner General Catalyst GP VIII, LLC · CIK 0001758432 · 10% owner General Catalyst Partners VIII, L.P. · CIK 0001758429 · 10% owner General Catalyst Group VIII, L.P. · CIK 0001663852 · 10% owner General Catalyst Group VIII Supplemental, L.P. · CIK 0001663855 · 10% owner CHENAULT KENNETH I · CIK 0001180524 · 10% owner Taneja Hemant · CIK 0001545563 · 10% owner Fialkow David P · CIK 0001337220 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Directly held by General Catalyst Group VIII, L.P. Disclosed balance after: 1,492,691 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Upon the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into shares of the Issuer's common stock on a one-for-one basis. F1 · price: Upon the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into shares of the Issuer's common stock on a one-for-one basis. F2 · ownership.nature: General Catalyst GP VIII, LLC ("GC VIII LLC") is the general partner of General Catalyst Partners VIII, L.P. ("GC VIII LP"), which is the general partner of General Catalyst Group VIII, L.P. ("CG Group VIII") and General Catalyst Group VIII Supplemental, L.P. ("CG Group VIII Supplemental"). General Catalyst Group Management, LLC ("GCGM") is the manager of GC VIII LLC. General Catalyst Group Management Holdings, L.P. ("GCGMH") is the manager of GCGM. F3 · ownership.nature: General Catalyst Group Management Holdings GP, LLC ("GCGMH LLC") is the general partner of GCGMH. Each of Kenneth Chenault, Joel Cutler, David Fialkow, and Hemant Taneja is a managing director of GCGMH LLC and shares voting and investment power over the shares held by GC Group VIII and GC Group VIII Supplemental. However, each Reporting Person disclaims beneficial ownership over such shares except to the extent of his or its pecuniary interest therein, if any. A Form 4 is being filed separately by Mr. Cutler in his capacity as a director of the Issuer. Read SEC document |
| June 24, 2020 Filed Jun 27, 2020 01:42 UTC | Livongo Health, Inc. LVGO · Entity 145566 | OtherCommon Stock | 3,907 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001012975-20-000590 · edgar.xml · nonDerivative · entry 1 Taneja Hemant · CIK 0001545563 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 971,064 F1 · kind: On June 24, 2020, shares of Common Stock of the Issuer held by 7wire Ventures Fund, L.P., were distributed to its underlying members. As part of such distribution, 7wire Investment Holdings, Ltd., which is wholly owned by General Catalyst Group VIII, L.P., received 3,907 shares of the Issuer's Common Stock. F2 · price: Pro rata distribution from a limited partnership of which the reporting person was a non-managing member. F3 · ownership.nature: 6,837 shares are held by 7wire Investment Holdings, Ltd. and the balance are held by General Catalyst Group VIII, L.P., or GC Group VIII LP. General Catalyst GP VIII, LLC, or GP VIII LLC, is the general partner of General Catalyst Partners VIII, L.P., or GP VIII LP, which is the general partner of GC Group VIII LP. General Catalyst Group Management, LLC, or GCGM, is the manager of GP VIII LLC. General Catalyst Group Management Holdings, L.P., or GCGMH, is the manager of GCGM. As a Managing Member of General Catalyst Group Management Holdings GP, LLC, the general partner of GCGMH, the reporting person shares voting and investment power with respect to shares held by 7wire Investment Holdings, Ltd. and GC Group VIII LP. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest in such securities. Read SEC document |
| May 19, 2020 Filed May 19, 2020 21:26 UTC | Livongo Health, Inc. LVGO · Entity 145566 | OtherCommon Stock | 14,048 | $0.00 | $0.00 |
DisclosureSEC source: 0001012975-20-000489 · edgar.xml · nonDerivative · entry 4 Taneja Hemant · CIK 0001545563 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,048 F5 · kind: Shares acquired through a distribution in-kind from GP VI LP. Read SEC document |
| May 19, 2020 Filed May 19, 2020 21:26 UTC | Livongo Health, Inc. LVGO · Entity 145566 | OtherCommon Stock | 131,939 | $0.00 | $0.00 |
DisclosureSEC source: 0001012975-20-000489 · edgar.xml · nonDerivative · entry 3 Taneja Hemant · CIK 0001545563 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 0 F4 · kind: Effective May 19, 2020, GP VI LP distributed in-kind, without consideration, a total of 131,939 shares of Common Stock of the Issuer to its limited partners. F4 · ownership.nature: Effective May 19, 2020, GP VI LP distributed in-kind, without consideration, a total of 131,939 shares of Common Stock of the Issuer to its limited partners. Read SEC document |
| May 15, 2020 Filed May 19, 2020 21:26 UTC | Livongo Health, Inc. LVGO · Entity 145566 | OtherCommon Stock | 131,939 | $0.00 | $0.00 |
DisclosureSEC source: 0001012975-20-000489 · edgar.xml · nonDerivative · entry 2 Taneja Hemant · CIK 0001545563 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 131,939 F3 · kind: Shares acquired through a distribution in-kind from GC Group VI LP by GP VI LP. As the Managing Members of GCGMH LLC, the general partner of GCGMH, Kenneth Chenault, Joel Cutler, David Fialkow and Hemant Taneja, a director of the Issuer, share voting and investment power with respect to the shares held by GP VI LP. Each of the reporting persons and entities disclaims beneficial ownership of the reported securities (except to the extent of such person's or entity's pecuniary interest in such securities). F3 · ownership.nature: Shares acquired through a distribution in-kind from GC Group VI LP by GP VI LP. As the Managing Members of GCGMH LLC, the general partner of GCGMH, Kenneth Chenault, Joel Cutler, David Fialkow and Hemant Taneja, a director of the Issuer, share voting and investment power with respect to the shares held by GP VI LP. Each of the reporting persons and entities disclaims beneficial ownership of the reported securities (except to the extent of such person's or entity's pecuniary interest in such securities). Read SEC document |
| May 15, 2020 Filed May 19, 2020 21:26 UTC | Livongo Health, Inc. LVGO · Entity 145566 | OtherCommon Stock | 2,000,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001012975-20-000489 · edgar.xml · nonDerivative · entry 1 Taneja Hemant · CIK 0001545563 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 13,943,216 F1 · kind: Effective May 15, 2020, shares of Common Stock of the Issuer held by General Catalyst Group VI, L.P. or GC Group VI LP, a venture capital partnership, distributed in-kind, without consideration, a total of 2,000,000 shares of Common Stock of the Issuer to its general and limited partners. F2 · kind: The remaining securities are held by GC Group VI LP. General Catalyst GP VI, LLC, or GP VI LLC, is the general partner of General Catalyst Partners VI, L.P., or GP VI LP, which is the general partner of GC Group VI LP. General Catalyst Group Management Holdings, L.P., or GCGMH, is the manager of General Catalyst Group Management, LLC, or GCGM, which is the manager of GP VI LLC. As the Managing Members of General Catalyst Group Management Holdings GP, LLC, or GCGMH LLC, the general partner of GCGMH, Kenneth Chenault, Joel Cutler, David Fialkow and Hemant Taneja, a director of the Issuer, share voting and investment power with respect to the shares held by GC Group VI LP. Each of the reporting persons and entities disclaims beneficial ownership of the reported securities (except to the extent of such person's or entity's pecuniary interest in such securities). F1 · ownership.nature: Effective May 15, 2020, shares of Common Stock of the Issuer held by General Catalyst Group VI, L.P. or GC Group VI LP, a venture capital partnership, distributed in-kind, without consideration, a total of 2,000,000 shares of Common Stock of the Issuer to its general and limited partners. F2 · ownership.nature: The remaining securities are held by GC Group VI LP. General Catalyst GP VI, LLC, or GP VI LLC, is the general partner of General Catalyst Partners VI, L.P., or GP VI LP, which is the general partner of GC Group VI LP. General Catalyst Group Management Holdings, L.P., or GCGMH, is the manager of General Catalyst Group Management, LLC, or GCGM, which is the manager of GP VI LLC. As the Managing Members of General Catalyst Group Management Holdings GP, LLC, or GCGMH LLC, the general partner of GCGMH, Kenneth Chenault, Joel Cutler, David Fialkow and Hemant Taneja, a director of the Issuer, share voting and investment power with respect to the shares held by GC Group VI LP. Each of the reporting persons and entities disclaims beneficial ownership of the reported securities (except to the extent of such person's or entity's pecuniary interest in such securities). Read SEC document |
| May 11, 2020 Filed May 13, 2020 01:40 UTC | Livongo Health, Inc. LVGO · Entity 145566 | SaleCommon Stock | 6,900 | $54.00 | $372,600.00 |
DisclosureSEC source: 0001012975-20-000421 · edgar.xml · nonDerivative · entry 3 Taneja Hemant · CIK 0001545563 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 15,943,216 F3 · ownership.nature: The shares are held of record by General Catalyst Group VI, L.P., or GC Group VI LP. General Catalyst GP VI, LLC, or GP VI LLC, is the general partner of General Catalyst Partners VI, L.P., or GP VI LP, which is the general partner of GC Group VI LP. General Catalyst Group Management Holdings, L.P., or GCGMH, is the manager of General Catalyst Group Management, LLC, or GCGM, which is the manager of GP VI LLC. As a Managing Member of General Catalyst Group Management Holdings GP, LLC, the general partner of GCGMH, the reporting person shares voting and investment power with respect to the shares held by GC Group VI, L.P. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest in such securities. Read SEC document |
| May 11, 2020 Filed May 13, 2020 01:40 UTC | Livongo Health, Inc. LVGO · Entity 145566 | SaleCommon Stock | 120,369 | $53.24 | $6,408,445.56 |
DisclosureSEC source: 0001012975-20-000421 · edgar.xml · nonDerivative · entry 2 Taneja Hemant · CIK 0001545563 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 15,950,116 F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $53.00 to $53.95, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: The shares are held of record by General Catalyst Group VI, L.P., or GC Group VI LP. General Catalyst GP VI, LLC, or GP VI LLC, is the general partner of General Catalyst Partners VI, L.P., or GP VI LP, which is the general partner of GC Group VI LP. General Catalyst Group Management Holdings, L.P., or GCGMH, is the manager of General Catalyst Group Management, LLC, or GCGM, which is the manager of GP VI LLC. As a Managing Member of General Catalyst Group Management Holdings GP, LLC, the general partner of GCGMH, the reporting person shares voting and investment power with respect to the shares held by GC Group VI, L.P. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest in such securities. Read SEC document |
| May 11, 2020 Filed May 13, 2020 01:40 UTC | Livongo Health, Inc. LVGO · Entity 145566 | SaleCommon Stock | 172,731 | $52.59 | $9,083,923.29 |
DisclosureSEC source: 0001012975-20-000421 · edgar.xml · nonDerivative · entry 1 Taneja Hemant · CIK 0001545563 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 16,070,485 F1 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $52.00 to $52.99, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: The shares are held of record by General Catalyst Group VI, L.P., or GC Group VI LP. General Catalyst GP VI, LLC, or GP VI LLC, is the general partner of General Catalyst Partners VI, L.P., or GP VI LP, which is the general partner of GC Group VI LP. General Catalyst Group Management Holdings, L.P., or GCGMH, is the manager of General Catalyst Group Management, LLC, or GCGM, which is the manager of GP VI LLC. As a Managing Member of General Catalyst Group Management Holdings GP, LLC, the general partner of GCGMH, the reporting person shares voting and investment power with respect to the shares held by GC Group VI, L.P. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest in such securities. Read SEC document |
| April 09, 2020 Filed Apr 14, 2020 01:47 UTC | Livongo Health, Inc. LVGO · Entity 145566 | OtherCommon Stock | 2,930 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001012975-20-000386 · edgar.xml · nonDerivative · entry 1 Taneja Hemant · CIK 0001545563 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 967,157 F1 · kind: On April 9, 2020, shares of Common Stock of the Issuer held by 7wire Ventures Fund, L.P., were distributed to its underlying members. As part of such distribution, 7wire Investment Holdings, Ltd., which is wholly owned by General Catalyst Group VIII, L.P., received 2,930 shares of the Issuer's Common Stock. F2 · price: Pro rata distribution from a limited partnership of which the reporting person was a non-managing member. F3 · ownership.nature: The shares are held of record by 7wire Investment Holdings, Ltd., which is wholly owned by General Catalyst Group VIII, L.P., or GC Group VIII LP. General Catalyst GP VIII, LLC, or GP VIII LLC, is the general partner of General Catalyst Partners VIII, L.P., or GP VIII LP, which is the general partner of GC Group VIII LP. General Catalyst Group Management, LLC, or GCGM, is the manager of GP VIII LLC. General Catalyst Group Management Holdings, L.P., or GCGMH, is the manager of GCGM. As a Managing Member of General Catalyst Group Management Holdings GP, LLC, the general partner of GCGMH, the reporting person shares voting and investment power with respect to the shares held by 7wire Investment Holdings, Ltd. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest in such securities. Read SEC document |
| July 29, 2019 Filed Aug 1, 2019 00:29 UTC | Livongo Health, Inc. LVGO · Entity 145566 | ConversionSeries E Convertible Preferred Stock · Derivative | 2,892,681 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-19-020759 · doc4.xml · derivative · entry 10 Taneja Hemant · CIK 0001545563 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 0 Underlying: Common Stock · 2,892,681 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_price: Each share of Series E Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering of Common Stock and had no expiration date. F6 · price: Each share of Series E Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering of Common Stock and had no expiration date. F6 · derivative.exercise_date: Each share of Series E Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering of Common Stock and had no expiration date. F6 · derivative.expiration_date: Each share of Series E Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering of Common Stock and had no expiration date. F8 · ownership.nature: The shares are held of record by General Catalyst Group VIII Supplemental, L.P., or GC Group VIII Supplemental. GP VIII LLC is the general partner of GP VIII LP, which is the general partner of GC Group VIII Supplemental. GCGMH is the manager of GCGM, which is the manager of GP VIII LLC. As a Managing Member of GCGMH LLC, the general partner of GCGMH, the reporting person shares voting and investment power with respect to the shares held by GC Group VIII Supplemental. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest in such securities. Read SEC document |
| July 29, 2019 Filed Aug 1, 2019 00:29 UTC | Livongo Health, Inc. LVGO · Entity 145566 | ConversionSeries E Convertible Preferred Stock · Derivative | 964,227 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-19-020759 · doc4.xml · derivative · entry 9 Taneja Hemant · CIK 0001545563 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 0 Underlying: Common Stock · 964,227 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_price: Each share of Series E Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering of Common Stock and had no expiration date. F6 · price: Each share of Series E Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering of Common Stock and had no expiration date. F6 · derivative.exercise_date: Each share of Series E Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering of Common Stock and had no expiration date. F6 · derivative.expiration_date: Each share of Series E Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering of Common Stock and had no expiration date. F7 · ownership.nature: The shares are held of record by General Catalyst Group VIII, L.P., or GC Group VIII LP. General Catalyst GP VIII, LLC, or GP VIII LLC, is the general partner of General Catalyst Partners VIII, L.P., or GP VIII LP, which is the general partner of GC Group VIII LP. GCGMH is the manager of GCGM, which is the manager of GP VIII LLC. As a Managing Member of GCGMH LLC, the general partner of GCGMH, the reporting person shares voting and investment power with respect to the shares held by GC Group VIII LP. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest in such securities. Read SEC document |
| July 29, 2019 Filed Aug 1, 2019 00:29 UTC | Livongo Health, Inc. LVGO · Entity 145566 | ConversionSeries D Convertible Preferred Stock · Derivative | 2,242,655 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-19-020759 · doc4.xml · derivative · entry 8 Taneja Hemant · CIK 0001545563 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 0 Underlying: Common Stock · 2,242,655 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: Each share of Series D Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering of Common Stock and had no expiration date. F5 · price: Each share of Series D Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering of Common Stock and had no expiration date. F5 · derivative.exercise_date: Each share of Series D Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering of Common Stock and had no expiration date. F5 · derivative.expiration_date: Each share of Series D Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering of Common Stock and had no expiration date. F2 · ownership.nature: The shares are held of record by General Catalyst Group VI, L.P., or GC Group VI LP. General Catalyst GP VI, LLC, or GP VI LLC, is the general partner of General Catalyst Partners VI, L.P., or GP VI LP, which is the general partner of GC Group VI LP. General Catalyst Group Management Holdings, L.P., or GCGMH, is the manager of General Catalyst Group Management, LLC, or GCGM, which is the manager of GP VI LLC. As a Managing Member of General Catalyst Group Management Holdings GP, LLC, or GCGMH LLC, the general partner of GCGMH, the reporting person shares voting and investment power with respect to the shares held by GC Group VI LP. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest in such securities. Read SEC document |
| July 29, 2019 Filed Aug 1, 2019 00:29 UTC | Livongo Health, Inc. LVGO · Entity 145566 | ConversionSeries C Convertible Preferred Stock · Derivative | 1,125,517 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-19-020759 · doc4.xml · derivative · entry 7 Taneja Hemant · CIK 0001545563 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 0 Underlying: Common Stock · 1,125,517 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each share of Series C Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering of Common Stock and had no expiration date. F4 · price: Each share of Series C Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering of Common Stock and had no expiration date. F4 · derivative.exercise_date: Each share of Series C Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering of Common Stock and had no expiration date. F4 · derivative.expiration_date: Each share of Series C Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering of Common Stock and had no expiration date. F2 · ownership.nature: The shares are held of record by General Catalyst Group VI, L.P., or GC Group VI LP. General Catalyst GP VI, LLC, or GP VI LLC, is the general partner of General Catalyst Partners VI, L.P., or GP VI LP, which is the general partner of GC Group VI LP. General Catalyst Group Management Holdings, L.P., or GCGMH, is the manager of General Catalyst Group Management, LLC, or GCGM, which is the manager of GP VI LLC. As a Managing Member of General Catalyst Group Management Holdings GP, LLC, or GCGMH LLC, the general partner of GCGMH, the reporting person shares voting and investment power with respect to the shares held by GC Group VI LP. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest in such securities. Read SEC document |
| July 29, 2019 Filed Aug 1, 2019 00:29 UTC | Livongo Health, Inc. LVGO · Entity 145566 | ConversionSeries B Convertible Preferred Stock · Derivative | 446,747 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-19-020759 · doc4.xml · derivative · entry 6 Taneja Hemant · CIK 0001545563 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 0 Underlying: Common Stock · 446,747 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each share of Series B Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering of Common Stock and had no expiration date. F3 · price: Each share of Series B Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering of Common Stock and had no expiration date. F3 · derivative.exercise_date: Each share of Series B Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering of Common Stock and had no expiration date. F3 · derivative.expiration_date: Each share of Series B Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering of Common Stock and had no expiration date. F2 · ownership.nature: The shares are held of record by General Catalyst Group VI, L.P., or GC Group VI LP. General Catalyst GP VI, LLC, or GP VI LLC, is the general partner of General Catalyst Partners VI, L.P., or GP VI LP, which is the general partner of GC Group VI LP. General Catalyst Group Management Holdings, L.P., or GCGMH, is the manager of General Catalyst Group Management, LLC, or GCGM, which is the manager of GP VI LLC. As a Managing Member of General Catalyst Group Management Holdings GP, LLC, or GCGMH LLC, the general partner of GCGMH, the reporting person shares voting and investment power with respect to the shares held by GC Group VI LP. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest in such securities. Read SEC document |
| July 29, 2019 Filed Aug 1, 2019 00:29 UTC | Livongo Health, Inc. LVGO · Entity 145566 | ConversionSeries A Convertible Preferred Stock · Derivative | 9,271,910 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-19-020759 · doc4.xml · derivative · entry 5 Taneja Hemant · CIK 0001545563 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 0 Underlying: Common Stock · 9,271,910 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each share of Series A Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering of Common Stock and had no expiration date. F1 · price: Each share of Series A Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering of Common Stock and had no expiration date. F1 · derivative.exercise_date: Each share of Series A Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering of Common Stock and had no expiration date. F1 · derivative.expiration_date: Each share of Series A Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering of Common Stock and had no expiration date. F2 · ownership.nature: The shares are held of record by General Catalyst Group VI, L.P., or GC Group VI LP. General Catalyst GP VI, LLC, or GP VI LLC, is the general partner of General Catalyst Partners VI, L.P., or GP VI LP, which is the general partner of GC Group VI LP. General Catalyst Group Management Holdings, L.P., or GCGMH, is the manager of General Catalyst Group Management, LLC, or GCGM, which is the manager of GP VI LLC. As a Managing Member of General Catalyst Group Management Holdings GP, LLC, or GCGMH LLC, the general partner of GCGMH, the reporting person shares voting and investment power with respect to the shares held by GC Group VI LP. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest in such securities. Read SEC document |
| July 29, 2019 Filed Aug 1, 2019 00:29 UTC | Livongo Health, Inc. LVGO · Entity 145566 | PurchaseCommon Stock | 2,678,571 | $28.00 | $74,999,988.00 |
DisclosureSEC source: 0000899243-19-020759 · doc4.xml · nonDerivative · entry 4 Taneja Hemant · CIK 0001545563 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 2,678,571 F9 · ownership.nature: The shares are held of record by GC Venture LH, LLC. GCGMH is the manager of GCGM, which is the manager of GC Venture LH Manager, LLC, which is the manager of GC Venture LH, LLC. As a Managing Member of GCGMH LLC, the general partner of GCGMH, the reporting person shares voting and investment power with respect to the shares held by GC Venture LH, LLC. GCGM Investment Holdings, L.P. is a non managing member of GC Venture LH Manager with a pecuniary interest in the reported securities. GC Partners Holdings, L.P. is a limited partner of GCGM Investment Holdings with a pecuniary interested in the reported securities. Each of the reporting persons and entities disclaims beneficial ownership of the reported securities (except to the extent of such person's or entity's pecuniary interest in such securities). Read SEC document |
| July 29, 2019 Filed Aug 1, 2019 00:29 UTC | Livongo Health, Inc. LVGO · Entity 145566 | ConversionCommon Stock | 2,892,681 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-19-020759 · doc4.xml · nonDerivative · entry 3 Taneja Hemant · CIK 0001545563 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 2,892,681 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · price: Each share of Series E Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering of Common Stock and had no expiration date. F8 · ownership.nature: The shares are held of record by General Catalyst Group VIII Supplemental, L.P., or GC Group VIII Supplemental. GP VIII LLC is the general partner of GP VIII LP, which is the general partner of GC Group VIII Supplemental. GCGMH is the manager of GCGM, which is the manager of GP VIII LLC. As a Managing Member of GCGMH LLC, the general partner of GCGMH, the reporting person shares voting and investment power with respect to the shares held by GC Group VIII Supplemental. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest in such securities. Read SEC document |
| July 29, 2019 Filed Aug 1, 2019 00:29 UTC | Livongo Health, Inc. LVGO · Entity 145566 | ConversionCommon Stock | 964,227 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-19-020759 · doc4.xml · nonDerivative · entry 2 Taneja Hemant · CIK 0001545563 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 964,227 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · price: Each share of Series E Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering of Common Stock and had no expiration date. F7 · ownership.nature: The shares are held of record by General Catalyst Group VIII, L.P., or GC Group VIII LP. General Catalyst GP VIII, LLC, or GP VIII LLC, is the general partner of General Catalyst Partners VIII, L.P., or GP VIII LP, which is the general partner of GC Group VIII LP. GCGMH is the manager of GCGM, which is the manager of GP VIII LLC. As a Managing Member of GCGMH LLC, the general partner of GCGMH, the reporting person shares voting and investment power with respect to the shares held by GC Group VIII LP. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest in such securities. Read SEC document |
| July 29, 2019 Filed Aug 1, 2019 00:29 UTC | Livongo Health, Inc. LVGO · Entity 145566 | ConversionCommon Stock | 13,086,829 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-19-020759 · doc4.xml · nonDerivative · entry 1 Taneja Hemant · CIK 0001545563 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 16,243,216 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each share of Series A Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering of Common Stock and had no expiration date. F3 · price: Each share of Series B Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering of Common Stock and had no expiration date. F4 · price: Each share of Series C Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering of Common Stock and had no expiration date. F5 · price: Each share of Series D Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering of Common Stock and had no expiration date. F2 · ownership.nature: The shares are held of record by General Catalyst Group VI, L.P., or GC Group VI LP. General Catalyst GP VI, LLC, or GP VI LLC, is the general partner of General Catalyst Partners VI, L.P., or GP VI LP, which is the general partner of GC Group VI LP. General Catalyst Group Management Holdings, L.P., or GCGMH, is the manager of General Catalyst Group Management, LLC, or GCGM, which is the manager of GP VI LLC. As a Managing Member of General Catalyst Group Management Holdings GP, LLC, or GCGMH LLC, the general partner of GCGMH, the reporting person shares voting and investment power with respect to the shares held by GC Group VI LP. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest in such securities. Read SEC document |
| January 11, 2019 Filed Jan 15, 2019 18:20 UTC | INTERSECTIONS INC INTX · Entity 161039 | OtherSenior Convertible Note · Derivative | 30,055,000 | Not disclosed Strike: $2.27 | Not disclosed |
DisclosureSEC source: 0000899243-19-001238 · doc4.xml · derivative · entry 5 General Catalyst Group IX, L.P. · CIK 0001732036 · 10% owner GC Entrepreneurs Fund IX, L.P. · CIK 0001732039 · 10% owner General Catalyst Partners IX, L.P. · CIK 0001732034 · 10% owner General Catalyst GP IX, LLC · CIK 0001732035 · 10% owner General Catalyst Group Management, LLC · CIK 0001637946 · 10% owner CHENAULT KENNETH I · CIK 0001180524 · 10% owner Cutler Joel E · CIK 0001337122 · 10% owner Fialkow David P · CIK 0001337220 · 10% owner Taneja Hemant · CIK 0001545563 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 0 Underlying: Common Stock · 13,240,089 shares Expires 2021-10-31 F3 · derivative.exercise_price: On January 11, 2019, Parent completed its acquisition of the Company pursuant to the terms of that certain Agreement and Plan of Merger, dated as of October 31, 2018, as amended (the "Merger Agreement"), by and among Parent, Merger Sub and the Company, wherein Merger Sub merged with and into the Company, with the Company surviving as an indirect wholly-owned subsidiary of Parent (the "Merger"). Pursuant to the terms of the Merger Agreement, Merger Sub conducted a tender offer (the "Offer") for all issued and outstanding shares of Common Stock (other than certain shares that certain stockholders agreed to roll over in the transaction), at a price of $3.68 per share, in cash, without interest and less any applicable withholding taxes. The Offer expired on January 4, 2019 at 5 p.m. New York City time. On January 7, 2019, Merger Sub accepted for payment all shares validly tendered and not withdrawn in the Offer. F4 · derivative.exercise_price: On January 11, 2019, immediately prior to the effective time of the Merger, the outstanding principal balance of the senior convertible note held by Parent (the "Parent Note"), together with all accrued and unpaid interest thereon, automatically converted in accordance with its terms into shares of Common Stock, at a conversion price equal to $2.27 per share. The terms of the Parent Note, which was purchased by Parent in an aggregate principal amount of $30,000,000 on October 31, 2018, provided that it would convert into shares of Common Stock or the Company's 6.0% Series A Preferred Stock, par value $0.01 per share, as applicable, pursuant to the terms of the Note Purchase and Exchange Agreement, dated as of October 31, 2018, by and among the Company, Parent and the other noteholders. F3 · kind: On January 11, 2019, Parent completed its acquisition of the Company pursuant to the terms of that certain Agreement and Plan of Merger, dated as of October 31, 2018, as amended (the "Merger Agreement"), by and among Parent, Merger Sub and the Company, wherein Merger Sub merged with and into the Company, with the Company surviving as an indirect wholly-owned subsidiary of Parent (the "Merger"). Pursuant to the terms of the Merger Agreement, Merger Sub conducted a tender offer (the "Offer") for all issued and outstanding shares of Common Stock (other than certain shares that certain stockholders agreed to roll over in the transaction), at a price of $3.68 per share, in cash, without interest and less any applicable withholding taxes. The Offer expired on January 4, 2019 at 5 p.m. New York City time. On January 7, 2019, Merger Sub accepted for payment all shares validly tendered and not withdrawn in the Offer. F4 · kind: On January 11, 2019, immediately prior to the effective time of the Merger, the outstanding principal balance of the senior convertible note held by Parent (the "Parent Note"), together with all accrued and unpaid interest thereon, automatically converted in accordance with its terms into shares of Common Stock, at a conversion price equal to $2.27 per share. The terms of the Parent Note, which was purchased by Parent in an aggregate principal amount of $30,000,000 on October 31, 2018, provided that it would convert into shares of Common Stock or the Company's 6.0% Series A Preferred Stock, par value $0.01 per share, as applicable, pursuant to the terms of the Note Purchase and Exchange Agreement, dated as of October 31, 2018, by and among the Company, Parent and the other noteholders. F3 · shares: On January 11, 2019, Parent completed its acquisition of the Company pursuant to the terms of that certain Agreement and Plan of Merger, dated as of October 31, 2018, as amended (the "Merger Agreement"), by and among Parent, Merger Sub and the Company, wherein Merger Sub merged with and into the Company, with the Company surviving as an indirect wholly-owned subsidiary of Parent (the "Merger"). Pursuant to the terms of the Merger Agreement, Merger Sub conducted a tender offer (the "Offer") for all issued and outstanding shares of Common Stock (other than certain shares that certain stockholders agreed to roll over in the transaction), at a price of $3.68 per share, in cash, without interest and less any applicable withholding taxes. The Offer expired on January 4, 2019 at 5 p.m. New York City time. On January 7, 2019, Merger Sub accepted for payment all shares validly tendered and not withdrawn in the Offer. F4 · shares: On January 11, 2019, immediately prior to the effective time of the Merger, the outstanding principal balance of the senior convertible note held by Parent (the "Parent Note"), together with all accrued and unpaid interest thereon, automatically converted in accordance with its terms into shares of Common Stock, at a conversion price equal to $2.27 per share. The terms of the Parent Note, which was purchased by Parent in an aggregate principal amount of $30,000,000 on October 31, 2018, provided that it would convert into shares of Common Stock or the Company's 6.0% Series A Preferred Stock, par value $0.01 per share, as applicable, pursuant to the terms of the Note Purchase and Exchange Agreement, dated as of October 31, 2018, by and among the Company, Parent and the other noteholders. F5 · shares: As of January 11, 2019, the Parent Note had $30,000,000 in outstanding principal balance and had accrued $55,000 in unpaid interest, for a total of $30,055,000. At a conversion price of $2.27 per share, the Parent Note was converted into 13,240,089 shares of Common Stock in accordance with the terms of the Parent Note (the "Note Conversion Shares"). F4 · price: On January 11, 2019, immediately prior to the effective time of the Merger, the outstanding principal balance of the senior convertible note held by Parent (the "Parent Note"), together with all accrued and unpaid interest thereon, automatically converted in accordance with its terms into shares of Common Stock, at a conversion price equal to $2.27 per share. The terms of the Parent Note, which was purchased by Parent in an aggregate principal amount of $30,000,000 on October 31, 2018, provided that it would convert into shares of Common Stock or the Company's 6.0% Series A Preferred Stock, par value $0.01 per share, as applicable, pursuant to the terms of the Note Purchase and Exchange Agreement, dated as of October 31, 2018, by and among the Company, Parent and the other noteholders. F5 · price: As of January 11, 2019, the Parent Note had $30,000,000 in outstanding principal balance and had accrued $55,000 in unpaid interest, for a total of $30,055,000. At a conversion price of $2.27 per share, the Parent Note was converted into 13,240,089 shares of Common Stock in accordance with the terms of the Parent Note (the "Note Conversion Shares"). F4 · derivative.exercise_date: On January 11, 2019, immediately prior to the effective time of the Merger, the outstanding principal balance of the senior convertible note held by Parent (the "Parent Note"), together with all accrued and unpaid interest thereon, automatically converted in accordance with its terms into shares of Common Stock, at a conversion price equal to $2.27 per share. The terms of the Parent Note, which was purchased by Parent in an aggregate principal amount of $30,000,000 on October 31, 2018, provided that it would convert into shares of Common Stock or the Company's 6.0% Series A Preferred Stock, par value $0.01 per share, as applicable, pursuant to the terms of the Note Purchase and Exchange Agreement, dated as of October 31, 2018, by and among the Company, Parent and the other noteholders. F3 · derivative.underlying_shares: On January 11, 2019, Parent completed its acquisition of the Company pursuant to the terms of that certain Agreement and Plan of Merger, dated as of October 31, 2018, as amended (the "Merger Agreement"), by and among Parent, Merger Sub and the Company, wherein Merger Sub merged with and into the Company, with the Company surviving as an indirect wholly-owned subsidiary of Parent (the "Merger"). Pursuant to the terms of the Merger Agreement, Merger Sub conducted a tender offer (the "Offer") for all issued and outstanding shares of Common Stock (other than certain shares that certain stockholders agreed to roll over in the transaction), at a price of $3.68 per share, in cash, without interest and less any applicable withholding taxes. The Offer expired on January 4, 2019 at 5 p.m. New York City time. On January 7, 2019, Merger Sub accepted for payment all shares validly tendered and not withdrawn in the Offer. F4 · derivative.underlying_shares: On January 11, 2019, immediately prior to the effective time of the Merger, the outstanding principal balance of the senior convertible note held by Parent (the "Parent Note"), together with all accrued and unpaid interest thereon, automatically converted in accordance with its terms into shares of Common Stock, at a conversion price equal to $2.27 per share. The terms of the Parent Note, which was purchased by Parent in an aggregate principal amount of $30,000,000 on October 31, 2018, provided that it would convert into shares of Common Stock or the Company's 6.0% Series A Preferred Stock, par value $0.01 per share, as applicable, pursuant to the terms of the Note Purchase and Exchange Agreement, dated as of October 31, 2018, by and among the Company, Parent and the other noteholders. F5 · derivative.underlying_shares: As of January 11, 2019, the Parent Note had $30,000,000 in outstanding principal balance and had accrued $55,000 in unpaid interest, for a total of $30,055,000. At a conversion price of $2.27 per share, the Parent Note was converted into 13,240,089 shares of Common Stock in accordance with the terms of the Parent Note (the "Note Conversion Shares"). F10 · ownership.direct: Because of the relationship among the Reporting Persons, WC SACD, Parent and Merger Sub, each of the Reporting Persons may be deemed to indirectly beneficially own shares of Common Stock beneficially owned by Parent and Merger Sub. Each of the Reporting Persons disclaims beneficial ownership of the securities reported on this Form 4, except to the extent of its or his pecuniary interest therein, and the reporting of such securities on this Form 4 shall not be construed as an admission that any of the Reporting Persons is the beneficial owner thereof for purposes of Section 16 of the Securities Exchange Act of 1934 or for any other purpose. F1 · ownership.nature: This statement on Form 4 is being jointly filed by General Catalyst Group IX, L.P., a Delaware limited partnership ("GC IX"), GC Entrepreneurs Fund IX, L.P., a Delaware limited partnership (together with GC IX, the "GC Funds"), General Catalyst Partners IX, L.P., a Delaware limited partnership, General Catalyst GP IX, LLC, a Delaware limited liability company, General Catalyst Group Management, LLC, a Delaware limited liability company, Kenneth I. Chenault, Joel E. Cutler, David P. Fialkow and Hemant Taneja (collectively, the "Reporting Persons"), and relates to the common stock, par value $0.01 per share ("Common Stock"), of Intersections Inc., a Delaware corporation (the "Company"). The GC Funds are stockholders of a joint venture, WC SACD One, Inc., a Delaware corporation ("WC SACD"). WC SACD One Parent, Inc., a Delaware corporation ("Parent"), is a direct wholly-owned subsidiary of WC SACD. F2 · ownership.nature: (Continued from Footnote 1) Prior to the Merger (as defined below), WC SACD One Merger Sub, Inc., a Delaware corporation ("Merger Sub"), was a direct wholly-owned subsidiary of Parent. F10 · ownership.nature: Because of the relationship among the Reporting Persons, WC SACD, Parent and Merger Sub, each of the Reporting Persons may be deemed to indirectly beneficially own shares of Common Stock beneficially owned by Parent and Merger Sub. Each of the Reporting Persons disclaims beneficial ownership of the securities reported on this Form 4, except to the extent of its or his pecuniary interest therein, and the reporting of such securities on this Form 4 shall not be construed as an admission that any of the Reporting Persons is the beneficial owner thereof for purposes of Section 16 of the Securities Exchange Act of 1934 or for any other purpose. Read SEC document |
| January 11, 2019 Filed Jan 15, 2019 18:20 UTC | INTERSECTIONS INC INTX · Entity 161039 | OtherCommon Stock | 37,787,129 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-19-001238 · doc4.xml · nonDerivative · entry 4 General Catalyst Group IX, L.P. · CIK 0001732036 · 10% owner GC Entrepreneurs Fund IX, L.P. · CIK 0001732039 · 10% owner General Catalyst Partners IX, L.P. · CIK 0001732034 · 10% owner General Catalyst GP IX, LLC · CIK 0001732035 · 10% owner General Catalyst Group Management, LLC · CIK 0001637946 · 10% owner CHENAULT KENNETH I · CIK 0001180524 · 10% owner Cutler Joel E · CIK 0001337122 · 10% owner Fialkow David P · CIK 0001337220 · 10% owner Taneja Hemant · CIK 0001545563 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 0 F1 · security: This statement on Form 4 is being jointly filed by General Catalyst Group IX, L.P., a Delaware limited partnership ("GC IX"), GC Entrepreneurs Fund IX, L.P., a Delaware limited partnership (together with GC IX, the "GC Funds"), General Catalyst Partners IX, L.P., a Delaware limited partnership, General Catalyst GP IX, LLC, a Delaware limited liability company, General Catalyst Group Management, LLC, a Delaware limited liability company, Kenneth I. Chenault, Joel E. Cutler, David P. Fialkow and Hemant Taneja (collectively, the "Reporting Persons"), and relates to the common stock, par value $0.01 per share ("Common Stock"), of Intersections Inc., a Delaware corporation (the "Company"). The GC Funds are stockholders of a joint venture, WC SACD One, Inc., a Delaware corporation ("WC SACD"). WC SACD One Parent, Inc., a Delaware corporation ("Parent"), is a direct wholly-owned subsidiary of WC SACD. F2 · security: (Continued from Footnote 1) Prior to the Merger (as defined below), WC SACD One Merger Sub, Inc., a Delaware corporation ("Merger Sub"), was a direct wholly-owned subsidiary of Parent. F9 · kind: In accordance with the terms of the Merger Agreement, at the effective time of the Merger, all issued and outstanding shares of Common Stock held by Parent and Merger Sub were automatically cancelled in the Merger for no consideration. F9 · shares: In accordance with the terms of the Merger Agreement, at the effective time of the Merger, all issued and outstanding shares of Common Stock held by Parent and Merger Sub were automatically cancelled in the Merger for no consideration. F9 · price: In accordance with the terms of the Merger Agreement, at the effective time of the Merger, all issued and outstanding shares of Common Stock held by Parent and Merger Sub were automatically cancelled in the Merger for no consideration. F9 · balance_after: In accordance with the terms of the Merger Agreement, at the effective time of the Merger, all issued and outstanding shares of Common Stock held by Parent and Merger Sub were automatically cancelled in the Merger for no consideration. F1 · ownership.nature: This statement on Form 4 is being jointly filed by General Catalyst Group IX, L.P., a Delaware limited partnership ("GC IX"), GC Entrepreneurs Fund IX, L.P., a Delaware limited partnership (together with GC IX, the "GC Funds"), General Catalyst Partners IX, L.P., a Delaware limited partnership, General Catalyst GP IX, LLC, a Delaware limited liability company, General Catalyst Group Management, LLC, a Delaware limited liability company, Kenneth I. Chenault, Joel E. Cutler, David P. Fialkow and Hemant Taneja (collectively, the "Reporting Persons"), and relates to the common stock, par value $0.01 per share ("Common Stock"), of Intersections Inc., a Delaware corporation (the "Company"). The GC Funds are stockholders of a joint venture, WC SACD One, Inc., a Delaware corporation ("WC SACD"). WC SACD One Parent, Inc., a Delaware corporation ("Parent"), is a direct wholly-owned subsidiary of WC SACD. F2 · ownership.nature: (Continued from Footnote 1) Prior to the Merger (as defined below), WC SACD One Merger Sub, Inc., a Delaware corporation ("Merger Sub"), was a direct wholly-owned subsidiary of Parent. F10 · ownership.nature: Because of the relationship among the Reporting Persons, WC SACD, Parent and Merger Sub, each of the Reporting Persons may be deemed to indirectly beneficially own shares of Common Stock beneficially owned by Parent and Merger Sub. Each of the Reporting Persons disclaims beneficial ownership of the securities reported on this Form 4, except to the extent of its or his pecuniary interest therein, and the reporting of such securities on this Form 4 shall not be construed as an admission that any of the Reporting Persons is the beneficial owner thereof for purposes of Section 16 of the Securities Exchange Act of 1934 or for any other purpose. Read SEC document |
| January 11, 2019 Filed Jan 15, 2019 18:20 UTC | INTERSECTIONS INC INTX · Entity 161039 | PurchaseCommon Stock | 13,443,400 | $3.38 | $45,438,692.00 |
DisclosureSEC source: 0000899243-19-001238 · doc4.xml · nonDerivative · entry 3 General Catalyst Group IX, L.P. · CIK 0001732036 · 10% owner GC Entrepreneurs Fund IX, L.P. · CIK 0001732039 · 10% owner General Catalyst Partners IX, L.P. · CIK 0001732034 · 10% owner General Catalyst GP IX, LLC · CIK 0001732035 · 10% owner General Catalyst Group Management, LLC · CIK 0001637946 · 10% owner CHENAULT KENNETH I · CIK 0001180524 · 10% owner Cutler Joel E · CIK 0001337122 · 10% owner Fialkow David P · CIK 0001337220 · 10% owner Taneja Hemant · CIK 0001545563 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 37,787,129 F1 · security: This statement on Form 4 is being jointly filed by General Catalyst Group IX, L.P., a Delaware limited partnership ("GC IX"), GC Entrepreneurs Fund IX, L.P., a Delaware limited partnership (together with GC IX, the "GC Funds"), General Catalyst Partners IX, L.P., a Delaware limited partnership, General Catalyst GP IX, LLC, a Delaware limited liability company, General Catalyst Group Management, LLC, a Delaware limited liability company, Kenneth I. Chenault, Joel E. Cutler, David P. Fialkow and Hemant Taneja (collectively, the "Reporting Persons"), and relates to the common stock, par value $0.01 per share ("Common Stock"), of Intersections Inc., a Delaware corporation (the "Company"). The GC Funds are stockholders of a joint venture, WC SACD One, Inc., a Delaware corporation ("WC SACD"). WC SACD One Parent, Inc., a Delaware corporation ("Parent"), is a direct wholly-owned subsidiary of WC SACD. F2 · security: (Continued from Footnote 1) Prior to the Merger (as defined below), WC SACD One Merger Sub, Inc., a Delaware corporation ("Merger Sub"), was a direct wholly-owned subsidiary of Parent. F3 · date: On January 11, 2019, Parent completed its acquisition of the Company pursuant to the terms of that certain Agreement and Plan of Merger, dated as of October 31, 2018, as amended (the "Merger Agreement"), by and among Parent, Merger Sub and the Company, wherein Merger Sub merged with and into the Company, with the Company surviving as an indirect wholly-owned subsidiary of Parent (the "Merger"). Pursuant to the terms of the Merger Agreement, Merger Sub conducted a tender offer (the "Offer") for all issued and outstanding shares of Common Stock (other than certain shares that certain stockholders agreed to roll over in the transaction), at a price of $3.68 per share, in cash, without interest and less any applicable withholding taxes. The Offer expired on January 4, 2019 at 5 p.m. New York City time. On January 7, 2019, Merger Sub accepted for payment all shares validly tendered and not withdrawn in the Offer. F8 · date: Represents (i) 13,435,388 shares of Common Stock owned directly by Merger Sub (which such shares were purchased by Merger Sub on January 7, 2019 in connection with the closing of the Offer) and (ii) 8,012 shares of Common Stock that were validly delivered pursuant to notice of guaranteed delivery procedures and purchased by Merger Sub upon closing of the Offer on January 11, 2019 (the "Tender Offer Shares"). F3 · kind: On January 11, 2019, Parent completed its acquisition of the Company pursuant to the terms of that certain Agreement and Plan of Merger, dated as of October 31, 2018, as amended (the "Merger Agreement"), by and among Parent, Merger Sub and the Company, wherein Merger Sub merged with and into the Company, with the Company surviving as an indirect wholly-owned subsidiary of Parent (the "Merger"). Pursuant to the terms of the Merger Agreement, Merger Sub conducted a tender offer (the "Offer") for all issued and outstanding shares of Common Stock (other than certain shares that certain stockholders agreed to roll over in the transaction), at a price of $3.68 per share, in cash, without interest and less any applicable withholding taxes. The Offer expired on January 4, 2019 at 5 p.m. New York City time. On January 7, 2019, Merger Sub accepted for payment all shares validly tendered and not withdrawn in the Offer. F3 · shares: On January 11, 2019, Parent completed its acquisition of the Company pursuant to the terms of that certain Agreement and Plan of Merger, dated as of October 31, 2018, as amended (the "Merger Agreement"), by and among Parent, Merger Sub and the Company, wherein Merger Sub merged with and into the Company, with the Company surviving as an indirect wholly-owned subsidiary of Parent (the "Merger"). Pursuant to the terms of the Merger Agreement, Merger Sub conducted a tender offer (the "Offer") for all issued and outstanding shares of Common Stock (other than certain shares that certain stockholders agreed to roll over in the transaction), at a price of $3.68 per share, in cash, without interest and less any applicable withholding taxes. The Offer expired on January 4, 2019 at 5 p.m. New York City time. On January 7, 2019, Merger Sub accepted for payment all shares validly tendered and not withdrawn in the Offer. F8 · shares: Represents (i) 13,435,388 shares of Common Stock owned directly by Merger Sub (which such shares were purchased by Merger Sub on January 7, 2019 in connection with the closing of the Offer) and (ii) 8,012 shares of Common Stock that were validly delivered pursuant to notice of guaranteed delivery procedures and purchased by Merger Sub upon closing of the Offer on January 11, 2019 (the "Tender Offer Shares"). F3 · price: On January 11, 2019, Parent completed its acquisition of the Company pursuant to the terms of that certain Agreement and Plan of Merger, dated as of October 31, 2018, as amended (the "Merger Agreement"), by and among Parent, Merger Sub and the Company, wherein Merger Sub merged with and into the Company, with the Company surviving as an indirect wholly-owned subsidiary of Parent (the "Merger"). Pursuant to the terms of the Merger Agreement, Merger Sub conducted a tender offer (the "Offer") for all issued and outstanding shares of Common Stock (other than certain shares that certain stockholders agreed to roll over in the transaction), at a price of $3.68 per share, in cash, without interest and less any applicable withholding taxes. The Offer expired on January 4, 2019 at 5 p.m. New York City time. On January 7, 2019, Merger Sub accepted for payment all shares validly tendered and not withdrawn in the Offer. F1 · ownership.nature: This statement on Form 4 is being jointly filed by General Catalyst Group IX, L.P., a Delaware limited partnership ("GC IX"), GC Entrepreneurs Fund IX, L.P., a Delaware limited partnership (together with GC IX, the "GC Funds"), General Catalyst Partners IX, L.P., a Delaware limited partnership, General Catalyst GP IX, LLC, a Delaware limited liability company, General Catalyst Group Management, LLC, a Delaware limited liability company, Kenneth I. Chenault, Joel E. Cutler, David P. Fialkow and Hemant Taneja (collectively, the "Reporting Persons"), and relates to the common stock, par value $0.01 per share ("Common Stock"), of Intersections Inc., a Delaware corporation (the "Company"). The GC Funds are stockholders of a joint venture, WC SACD One, Inc., a Delaware corporation ("WC SACD"). WC SACD One Parent, Inc., a Delaware corporation ("Parent"), is a direct wholly-owned subsidiary of WC SACD. F2 · ownership.nature: (Continued from Footnote 1) Prior to the Merger (as defined below), WC SACD One Merger Sub, Inc., a Delaware corporation ("Merger Sub"), was a direct wholly-owned subsidiary of Parent. F10 · ownership.nature: Because of the relationship among the Reporting Persons, WC SACD, Parent and Merger Sub, each of the Reporting Persons may be deemed to indirectly beneficially own shares of Common Stock beneficially owned by Parent and Merger Sub. Each of the Reporting Persons disclaims beneficial ownership of the securities reported on this Form 4, except to the extent of its or his pecuniary interest therein, and the reporting of such securities on this Form 4 shall not be construed as an admission that any of the Reporting Persons is the beneficial owner thereof for purposes of Section 16 of the Securities Exchange Act of 1934 or for any other purpose. Read SEC document |
| January 11, 2019 Filed Jan 15, 2019 18:20 UTC | INTERSECTIONS INC INTX · Entity 161039 | OtherCommon Stock | 11,103,640 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-19-001238 · doc4.xml · nonDerivative · entry 2 General Catalyst Group IX, L.P. · CIK 0001732036 · 10% owner GC Entrepreneurs Fund IX, L.P. · CIK 0001732039 · 10% owner General Catalyst Partners IX, L.P. · CIK 0001732034 · 10% owner General Catalyst GP IX, LLC · CIK 0001732035 · 10% owner General Catalyst Group Management, LLC · CIK 0001637946 · 10% owner CHENAULT KENNETH I · CIK 0001180524 · 10% owner Cutler Joel E · CIK 0001337122 · 10% owner Fialkow David P · CIK 0001337220 · 10% owner Taneja Hemant · CIK 0001545563 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 24,343,729 F1 · security: This statement on Form 4 is being jointly filed by General Catalyst Group IX, L.P., a Delaware limited partnership ("GC IX"), GC Entrepreneurs Fund IX, L.P., a Delaware limited partnership (together with GC IX, the "GC Funds"), General Catalyst Partners IX, L.P., a Delaware limited partnership, General Catalyst GP IX, LLC, a Delaware limited liability company, General Catalyst Group Management, LLC, a Delaware limited liability company, Kenneth I. Chenault, Joel E. Cutler, David P. Fialkow and Hemant Taneja (collectively, the "Reporting Persons"), and relates to the common stock, par value $0.01 per share ("Common Stock"), of Intersections Inc., a Delaware corporation (the "Company"). The GC Funds are stockholders of a joint venture, WC SACD One, Inc., a Delaware corporation ("WC SACD"). WC SACD One Parent, Inc., a Delaware corporation ("Parent"), is a direct wholly-owned subsidiary of WC SACD. F2 · security: (Continued from Footnote 1) Prior to the Merger (as defined below), WC SACD One Merger Sub, Inc., a Delaware corporation ("Merger Sub"), was a direct wholly-owned subsidiary of Parent. F6 · kind: Represents shares of Common Stock that were contributed and assigned, immediately prior to the effective time of the Merger, to WC SACD (the "Rollover Shares"), in exchange for equity interests in WC SACD, pursuant to the terms and conditions of those certain Contribution and Assignment Agreements, dated as of October 31, 2018, by and between WC SACD, on the one hand, and each of Loeb Holding Corporation, Michael Stanfield, Stanfield Family Investments LLC and David McGough, on the other hand. F7 · kind: Immediately following the contribution and assignment of the Rollover Shares to WC SACD and prior to the effective time of the Merger, WC SACD contributed and assigned the Rollover Shares to Parent. As such, Parent became the direct beneficial owner of the Rollover Shares. F6 · shares: Represents shares of Common Stock that were contributed and assigned, immediately prior to the effective time of the Merger, to WC SACD (the "Rollover Shares"), in exchange for equity interests in WC SACD, pursuant to the terms and conditions of those certain Contribution and Assignment Agreements, dated as of October 31, 2018, by and between WC SACD, on the one hand, and each of Loeb Holding Corporation, Michael Stanfield, Stanfield Family Investments LLC and David McGough, on the other hand. F7 · shares: Immediately following the contribution and assignment of the Rollover Shares to WC SACD and prior to the effective time of the Merger, WC SACD contributed and assigned the Rollover Shares to Parent. As such, Parent became the direct beneficial owner of the Rollover Shares. F6 · price: Represents shares of Common Stock that were contributed and assigned, immediately prior to the effective time of the Merger, to WC SACD (the "Rollover Shares"), in exchange for equity interests in WC SACD, pursuant to the terms and conditions of those certain Contribution and Assignment Agreements, dated as of October 31, 2018, by and between WC SACD, on the one hand, and each of Loeb Holding Corporation, Michael Stanfield, Stanfield Family Investments LLC and David McGough, on the other hand. F1 · ownership.nature: This statement on Form 4 is being jointly filed by General Catalyst Group IX, L.P., a Delaware limited partnership ("GC IX"), GC Entrepreneurs Fund IX, L.P., a Delaware limited partnership (together with GC IX, the "GC Funds"), General Catalyst Partners IX, L.P., a Delaware limited partnership, General Catalyst GP IX, LLC, a Delaware limited liability company, General Catalyst Group Management, LLC, a Delaware limited liability company, Kenneth I. Chenault, Joel E. Cutler, David P. Fialkow and Hemant Taneja (collectively, the "Reporting Persons"), and relates to the common stock, par value $0.01 per share ("Common Stock"), of Intersections Inc., a Delaware corporation (the "Company"). The GC Funds are stockholders of a joint venture, WC SACD One, Inc., a Delaware corporation ("WC SACD"). WC SACD One Parent, Inc., a Delaware corporation ("Parent"), is a direct wholly-owned subsidiary of WC SACD. F2 · ownership.nature: (Continued from Footnote 1) Prior to the Merger (as defined below), WC SACD One Merger Sub, Inc., a Delaware corporation ("Merger Sub"), was a direct wholly-owned subsidiary of Parent. F10 · ownership.nature: Because of the relationship among the Reporting Persons, WC SACD, Parent and Merger Sub, each of the Reporting Persons may be deemed to indirectly beneficially own shares of Common Stock beneficially owned by Parent and Merger Sub. Each of the Reporting Persons disclaims beneficial ownership of the securities reported on this Form 4, except to the extent of its or his pecuniary interest therein, and the reporting of such securities on this Form 4 shall not be construed as an admission that any of the Reporting Persons is the beneficial owner thereof for purposes of Section 16 of the Securities Exchange Act of 1934 or for any other purpose. Read SEC document |
| January 11, 2019 Filed Jan 15, 2019 18:20 UTC | INTERSECTIONS INC INTX · Entity 161039 | OtherCommon Stock | 13,240,089 | $2.27 | $30,055,002.03 |
DisclosureSEC source: 0000899243-19-001238 · doc4.xml · nonDerivative · entry 1 General Catalyst Group IX, L.P. · CIK 0001732036 · 10% owner GC Entrepreneurs Fund IX, L.P. · CIK 0001732039 · 10% owner General Catalyst Partners IX, L.P. · CIK 0001732034 · 10% owner General Catalyst GP IX, LLC · CIK 0001732035 · 10% owner General Catalyst Group Management, LLC · CIK 0001637946 · 10% owner CHENAULT KENNETH I · CIK 0001180524 · 10% owner Cutler Joel E · CIK 0001337122 · 10% owner Fialkow David P · CIK 0001337220 · 10% owner Taneja Hemant · CIK 0001545563 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 13,240,089 F1 · security: This statement on Form 4 is being jointly filed by General Catalyst Group IX, L.P., a Delaware limited partnership ("GC IX"), GC Entrepreneurs Fund IX, L.P., a Delaware limited partnership (together with GC IX, the "GC Funds"), General Catalyst Partners IX, L.P., a Delaware limited partnership, General Catalyst GP IX, LLC, a Delaware limited liability company, General Catalyst Group Management, LLC, a Delaware limited liability company, Kenneth I. Chenault, Joel E. Cutler, David P. Fialkow and Hemant Taneja (collectively, the "Reporting Persons"), and relates to the common stock, par value $0.01 per share ("Common Stock"), of Intersections Inc., a Delaware corporation (the "Company"). The GC Funds are stockholders of a joint venture, WC SACD One, Inc., a Delaware corporation ("WC SACD"). WC SACD One Parent, Inc., a Delaware corporation ("Parent"), is a direct wholly-owned subsidiary of WC SACD. F2 · security: (Continued from Footnote 1) Prior to the Merger (as defined below), WC SACD One Merger Sub, Inc., a Delaware corporation ("Merger Sub"), was a direct wholly-owned subsidiary of Parent. F3 · kind: On January 11, 2019, Parent completed its acquisition of the Company pursuant to the terms of that certain Agreement and Plan of Merger, dated as of October 31, 2018, as amended (the "Merger Agreement"), by and among Parent, Merger Sub and the Company, wherein Merger Sub merged with and into the Company, with the Company surviving as an indirect wholly-owned subsidiary of Parent (the "Merger"). Pursuant to the terms of the Merger Agreement, Merger Sub conducted a tender offer (the "Offer") for all issued and outstanding shares of Common Stock (other than certain shares that certain stockholders agreed to roll over in the transaction), at a price of $3.68 per share, in cash, without interest and less any applicable withholding taxes. The Offer expired on January 4, 2019 at 5 p.m. New York City time. On January 7, 2019, Merger Sub accepted for payment all shares validly tendered and not withdrawn in the Offer. F4 · kind: On January 11, 2019, immediately prior to the effective time of the Merger, the outstanding principal balance of the senior convertible note held by Parent (the "Parent Note"), together with all accrued and unpaid interest thereon, automatically converted in accordance with its terms into shares of Common Stock, at a conversion price equal to $2.27 per share. The terms of the Parent Note, which was purchased by Parent in an aggregate principal amount of $30,000,000 on October 31, 2018, provided that it would convert into shares of Common Stock or the Company's 6.0% Series A Preferred Stock, par value $0.01 per share, as applicable, pursuant to the terms of the Note Purchase and Exchange Agreement, dated as of October 31, 2018, by and among the Company, Parent and the other noteholders. F3 · shares: On January 11, 2019, Parent completed its acquisition of the Company pursuant to the terms of that certain Agreement and Plan of Merger, dated as of October 31, 2018, as amended (the "Merger Agreement"), by and among Parent, Merger Sub and the Company, wherein Merger Sub merged with and into the Company, with the Company surviving as an indirect wholly-owned subsidiary of Parent (the "Merger"). Pursuant to the terms of the Merger Agreement, Merger Sub conducted a tender offer (the "Offer") for all issued and outstanding shares of Common Stock (other than certain shares that certain stockholders agreed to roll over in the transaction), at a price of $3.68 per share, in cash, without interest and less any applicable withholding taxes. The Offer expired on January 4, 2019 at 5 p.m. New York City time. On January 7, 2019, Merger Sub accepted for payment all shares validly tendered and not withdrawn in the Offer. F4 · shares: On January 11, 2019, immediately prior to the effective time of the Merger, the outstanding principal balance of the senior convertible note held by Parent (the "Parent Note"), together with all accrued and unpaid interest thereon, automatically converted in accordance with its terms into shares of Common Stock, at a conversion price equal to $2.27 per share. The terms of the Parent Note, which was purchased by Parent in an aggregate principal amount of $30,000,000 on October 31, 2018, provided that it would convert into shares of Common Stock or the Company's 6.0% Series A Preferred Stock, par value $0.01 per share, as applicable, pursuant to the terms of the Note Purchase and Exchange Agreement, dated as of October 31, 2018, by and among the Company, Parent and the other noteholders. F5 · shares: As of January 11, 2019, the Parent Note had $30,000,000 in outstanding principal balance and had accrued $55,000 in unpaid interest, for a total of $30,055,000. At a conversion price of $2.27 per share, the Parent Note was converted into 13,240,089 shares of Common Stock in accordance with the terms of the Parent Note (the "Note Conversion Shares"). F4 · price: On January 11, 2019, immediately prior to the effective time of the Merger, the outstanding principal balance of the senior convertible note held by Parent (the "Parent Note"), together with all accrued and unpaid interest thereon, automatically converted in accordance with its terms into shares of Common Stock, at a conversion price equal to $2.27 per share. The terms of the Parent Note, which was purchased by Parent in an aggregate principal amount of $30,000,000 on October 31, 2018, provided that it would convert into shares of Common Stock or the Company's 6.0% Series A Preferred Stock, par value $0.01 per share, as applicable, pursuant to the terms of the Note Purchase and Exchange Agreement, dated as of October 31, 2018, by and among the Company, Parent and the other noteholders. F5 · price: As of January 11, 2019, the Parent Note had $30,000,000 in outstanding principal balance and had accrued $55,000 in unpaid interest, for a total of $30,055,000. At a conversion price of $2.27 per share, the Parent Note was converted into 13,240,089 shares of Common Stock in accordance with the terms of the Parent Note (the "Note Conversion Shares"). F5 · balance_after: As of January 11, 2019, the Parent Note had $30,000,000 in outstanding principal balance and had accrued $55,000 in unpaid interest, for a total of $30,055,000. At a conversion price of $2.27 per share, the Parent Note was converted into 13,240,089 shares of Common Stock in accordance with the terms of the Parent Note (the "Note Conversion Shares"). F1 · ownership.nature: This statement on Form 4 is being jointly filed by General Catalyst Group IX, L.P., a Delaware limited partnership ("GC IX"), GC Entrepreneurs Fund IX, L.P., a Delaware limited partnership (together with GC IX, the "GC Funds"), General Catalyst Partners IX, L.P., a Delaware limited partnership, General Catalyst GP IX, LLC, a Delaware limited liability company, General Catalyst Group Management, LLC, a Delaware limited liability company, Kenneth I. Chenault, Joel E. Cutler, David P. Fialkow and Hemant Taneja (collectively, the "Reporting Persons"), and relates to the common stock, par value $0.01 per share ("Common Stock"), of Intersections Inc., a Delaware corporation (the "Company"). The GC Funds are stockholders of a joint venture, WC SACD One, Inc., a Delaware corporation ("WC SACD"). WC SACD One Parent, Inc., a Delaware corporation ("Parent"), is a direct wholly-owned subsidiary of WC SACD. F2 · ownership.nature: (Continued from Footnote 1) Prior to the Merger (as defined below), WC SACD One Merger Sub, Inc., a Delaware corporation ("Merger Sub"), was a direct wholly-owned subsidiary of Parent. F10 · ownership.nature: Because of the relationship among the Reporting Persons, WC SACD, Parent and Merger Sub, each of the Reporting Persons may be deemed to indirectly beneficially own shares of Common Stock beneficially owned by Parent and Merger Sub. Each of the Reporting Persons disclaims beneficial ownership of the securities reported on this Form 4, except to the extent of its or his pecuniary interest therein, and the reporting of such securities on this Form 4 shall not be construed as an admission that any of the Reporting Persons is the beneficial owner thereof for purposes of Section 16 of the Securities Exchange Act of 1934 or for any other purpose. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.